methadone and naltrexone

methadone has been researched along with naltrexone in 438 studies

Research

Studies (438)

TimeframeStudies, this research(%)All Research%
pre-199090 (20.55)18.7374
1990's46 (10.50)18.2507
2000's83 (18.95)29.6817
2010's122 (27.85)24.3611
2020's97 (22.15)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Chang, TK; Ensom, MH; Kiang, TK1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Geller, I; Hartmann, RJ1
Ladewig, D1
Resnick, RB; Volavka, J1
Grabowski, J; Jordan-Hayes, J; O'Brien, CP; Ternes, JW; Wellerstein, H1
Chipkin, RE; Rosecrans, JA1
Ling, W2
Rawson, RA; Resnick, RB; Washton, AM1
Altman, JL; Meyer, RE; Mirin, SM1
Terenius, L1
Wikler, A2
Greenstein, R; O'Brien, CP; Woody, GE1
Kestenbaum, RS; Resnick, RB; Thomas, MA; Washton, AM1
Hui, FW; Krikun, E; Smith, AA1
Johnson, JH; Maughan, GT; Rosecrans, JA1
Blakis, M; Haas, N; Holmes, E; Ling, W; Litaker, M1
Keegan, J; Lavenduski, C; Schooff, K1
Cooperstein, J; Harris, M; Hough, G; Kauders, F; Resnick, R; Thomas, M1
Inturrisi, CE1
Brocco, MJ; Killam, KF; Robinson, CA1
Kestenbaum, RS; Poole, D; Resnick, RB; Washton, A1
Hollister, LE; Kasper, P; Schwin, RL1
Swanson, DA1
Blaiklock, RG; Hirsh, EM; Hui, FW; Krikun, E; Smith, AA1
Gray, AP; Guardina, WJ2
McNamee, HB; Meyer, RE; Mirin, SM1
Amico, L; Landsberg, R; Plumb, M; Taintor, Z; Wicks, N1
Chen, RC; Ho, AK1
Goldstein, A2
Greenstein, RA; Mintz, J; O'Brien, CP; Woody, GE1
Kauders, F; Schecter, A1
Craft, RM; Dykstra, LA1
Maneckjee, R; Minna, JD1
Billings, B; Candido, J; Duttaroy, A; Inturrisi, CE; Lutfy, K; Sierra, V; Yoburn, BC1
Kleber, HD; Kosten, TR; Morgan, C3
Bilsky, EJ; Delong, CL; Montegut, MJ; Reid, LD1
Goldberg, SR; Grayson, NA; Jaffe, JH; Johnson, RE; Katz, JL; Rice, KC; Witkin, JM1
Lenz, K; Loimer, N; Presslich, O; Schmid, R2
Caballero, L; Iruela, LM; Oliveros, SC1
Ling, W; Wesson, DR1
LoPresti, D; Porreca, F; Ward, SJ1
Dykstra, LA1
Adams, JU; Holtzman, SG; Paronis, CA1
Fraser, AD1
Charney, DS; Kleber, HD; Kosten, TR; Krystal, JH; Morgan, CH; Price, LH1
Bronson, ME; Sparber, SB1
Woody, G1
Schuster, CR; Snyder, M1
Fram, DH; Holden, R; Marmo, J1
Eriksson, I; McLellan, AT; Nyberg, F; O'Brien, CP; Terenius, LY1
Di Chiara, G; Imperato, A1
Carino, MA; Horita, A; Yamawaki, S1
Peachey, JE1
Harty, GJ; Onofrio, BM; Yaksh, TL1
Adams, M; Cushman, P; Dewey, W; Morris, D1
Kleber, HD2
Hynes, MD; Leander, JD; Reel, JK; Zimmerman, DM1
Gossop, M1
McLellan, AT; Nyberg, F; O'Brien, CP; Terenius, LY1
Brahen, LS; Capone, DM; Capone, TJ1
Williams, A1
Agren, H1
Kleber, HD; Kosten, TR; Rounsaville, BJ1
Charney, DS; Heninger, GR; Kleber, HD1
Grey, C; Osborn, E; Reznikoff, M2
Mello, NK; Mendelson, JH1
Moerschbaecher, JM; Thompson, DM; Winsauer, PJ1
Rawson, RA; Resnick, RB; Tennant, FS; Washton, AM2
Extein, I; Gold, MS; Kleber, HD; Pottash, AL2
Resnick, RB; Washton, AM4
Cerdeño Impuesto, V1
Clemens, JA; Shaar, CJ1
Schecter, A1
Extein, I; Gold, MS; Kleber, HD; Martin, D; Pottash, AC1
Frantz, AG; Kreek, MJ; Ragavan, VV; Wardlaw, SL1
Frenk, H; Mayer, DJ; Miller, J; Watkins, LR1
Goldstein, A; Inturrisi, CE; Judson, BA1
Childress, AR; Ehrman, RN; McLellan, AT; O'Brien, CP; Ternes, J1
Dackis, CA; Gold, MS1
Bigelow, GE; Sherman, MF; Singleton, EG1
Kleber, HD; Kosten, TR1
Charney, DS; Galloway, MP; Heninger, GR; Kleber, HD; Murberg, M; Redmond, DE; Roth, RH1
Greenstein, RA; Resnick, E; Resnick, RB1
Lynch, MR; Porter, JH; Rosecrans, JA1
Domino, EF; Ruffing, DM1
Krivoy, W; McLellan, AT; O'Brien, CP; Terenius, L; Wahlström, A1
Crits-Christoph, K; Kleber, H; Rounsaville, BJ; Weissman, MM; Wilber, C1
Braverman, P; Charney, DS; Heninger, GR; Kleber, HD; Murburg, M; Redmond, DE; Riordan, CE; Sternberg, DE1
Kirlangitis, J; Langley, AE; Lehman, TM; Zeid, R1
Johnson, JH; Rosecrans, JA1
Murphy, MR1
Jasinski, DR1
Kuehnle, JC; Mello, NK; Mendelson, JH; Sellers, MS1
Wodak, A1
Miguel, N; Patricio, LD1
Cavigliano, P; Fossati, G; Frigo, G; Lecchini, S; Mazzone, A; Mazzucchelli, I; Notario, A; Pasotti, D; Ricevuti, G1
Chang, KJ; Dykstra, LA; McNutt, R; Schoenbaum, GM; Yarbrough, J1
KOSTEN, TR1
Cutler, R; Fishbain, DA; Rosomoff, HL1
Gold, MS1
Chami, TN; Cheskin, LJ; Jaffe, JH; Johnson, RE1
Greenwood, J; Seivewright, NA1
Rounsaville, BJ1
Hajak, G; Poser, W; Rodenbeck, A; Rüther, E; Staedt, J; Stoppe, G; Wassmuth, F1
Simon, DL1
Ehrenreich, H; Poser, W1
Blansfield, HN1
Brandt, MR; Cabansag, SR; France, CP1
Fawcett, JP; Morgan, NC; Woods, DJ1
Gutiérrez Mora, E; Lozano Polo, JL; Martínez Pérez, V; Santamaría Gutiérrez, J; Vada Sánchez, J; Vallejo Correas, JA1
Barr, GA; Hamowy, AS; Hutchings, DE; Liu, PY; Wang, S; Zmitrovich, A1
Cheung, P; Li, JG; Liu-Chen, LY; Raffa, RB; Tzeng, TB1
Bargagli, AM; D'Ippoliti, D; Davoli, M; Pasqualini, F; Perucci, CA1
Bertschy, G; Cucchia, AT; Ferrero, F; Monnat, M; Spagnoli, J1
Morgan, D; Picker, MJ1
Hall, W; Mattick, RP; Ward, J1
Hirtl, C; Pfab, R; Zilker, T1
Simpson, S1
Hall, WD; Wodak, A1
Bammer, G; Bell, JR; Masterman, SC; Mattick, RP; Morris, A; Young, MR1
Barelli, A; De Giacomo, M; Gaspari, R; Mannelli, P; Stefanelli, A1
Foss, FJ; Moss, J; O'Connor, M; Osinski, J; Roizen, FM; Yuan, SC1
De Giacomo, M; De Risio, S; Janiri, L; Mannelli, P; Pozzi, G1
Foss, JF; Karrison, T; Moss, J; O'Connor, M; Osinski, J; Roizen, MF; Yuan, CS1
Sutherland, J; Walker, EA; Young, AM; Zhang, L1
Hensel, M; Kox, WJ1
Bocchi, C; Delsignore, R; Fontanesi, B; Gerra, G; Rustichelli, P; Timpano, M; Zaimovic, A; Zambelli, U1
Conte, G; De Risio, S; Pozzi, G1
Fiellin, DA; O'Connor, PG1
Bearn, J; Buntwal, N; Gossop, M; Strang, J1
Scholz, M1
Farrell, M; Keaney, F1
Cañadas, F; Rice, KC; Riley, AL; Stevenson, GW; Zhang, X1
Foss, JF; Yuan, CS1
Borg, L; Carson, RE; Eckelman, WC; Herscovitch, P; Ho, A; Kling, MA; Kreek, MJ; Matochik, JA; Rice, KC; Schluger, J; Zametkin, A1
Bisaga, A; Popik, P; Radomska, M1
Yui, K1
Brown, R; Lo, R1
Douglas, SD; Guo, CJ; Ho, WZ; Li, Y; Tian, S; Wang, X1
Stimmel, B1
Heilig, M2
Asplund, K; Jonsson, E1
Dhopesh, V; Fudala, PJ; Yu, E1
Alvarez, CE; Bascarán, MT; Bobes, J; Brewer, C; Carreño, JE; San Narciso, GI; Sánchez del Río, J1
Stephenson, J1
de Kan, R; Geerlings, PJ; Kerkhof, BJ; Roozen, HG; van den Brink, W1
Butelman, E; Kreek, MJ; LaForge, KS1
Bisaga, A; Foltin, RW; Haney, M1
Church, SH; Collins, E; Kleber, HD; Nunes, EV; Rothenberg, JL; Seracini, A; Sullivan, MA1
Holtzman, SG1
Borgland, SL; Christie, MJ; Connor, M; Furness, JB; Osborne, PB1
Kerkhof, AJ; Roozen, HG; van den Brink, W1
Barrett, AC; Picker, MJ; Smith, ES1
Compton, M; Ling, W; Rawson, RA1
Buonanno, A; De Risio, S; Gottheil, E; Mannelli, P1
Arbuck, DM; Cruciani, RA; Lussier, D; Miller-Saultz, D1
Colker, AC1
Ahmadi, J; Ahmadi, K; Ohaeri, J1
Aksel'rod, BA; Chichenkov, TO; Kubarev, DA; Savchenkov, VA; Sivolap, I1
Alvarez, CE; Bascarán, MT; Bobes, J; Carreño, JE; Díaz, M; Narciso, GI1
Digiusto, E; Mattick, RP; O'Brien, S; Ritter, A; Shakeshaft, A1
Golden, SA; Sakhrani, DL1
Arnold-Reed, DE; Hulse, GK; O'Neil, G1
Freye, E; Levy, JV; Partecke, L1
Beaini, AY; Carr, MP; Firth, AY; Pulling, S1
Bailey, KP1
Ali, R; Bell, J; Breen, C; Digiusto, E; Kimber, J; Lintzeris, N; Mattick, RP; Saunders, JB1
Ali, R; Bell, J; Digiusto, E; Doran, CM; Gilmour, S; Lintzeris, N; Mattick, RP; Saunders, JB; Shanahan, MD; White, J1
Antonilli, L; Badiani, A; Caprioli, D; Nencini, P; Petecchia, E1
Gölz, J; Grüsser, SM; Partecke, G; Platz, W; Thalemann, CN1
Cropsey, KL; St Clair, CL; Villalobos, GC1
Comer, SD; Dackis, C; Kampman, K; Kleber, HD; O'Brien, CP; Rothenberg, JL; Sullivan, MA; Yu, E1
Connor, JP; Dean, AJ; Jones, RT; Lawford, BR; Saunders, JB; Young, RM1
Cubells, JF; Tang, YL; Zhao, C; Zhao, D1
Ng, BY; Peh, LH1
Haney, M1
Besson, J; Camarasa, X; Khazaal, Y; Zullino, DF1
Stancliff, S1
Brady, KT1
Bluschke, SM; De Jong, CA; Dijkstra, BA; Krabbe, PF; van der Staak, CP1
Degenhardt, LJ; Gibson, AE1
Kreek, MJ; Novick, DM1
Petry, N; Stitzer, M1
Gardner, TJ; Kosten, TR1
Hulse, GK; Ngo, HT; Tait, RJ3
Greenwald, MK1
Saitz, R1
O'Brien, CP2
Casadonte, PP; Horton, T; Kolodner, GF; McMurphy, SM1
Amirshahrokhi, K; Dehpour, AR; Ghazi-Khansari, M; Hadjati, J; Sotoudeh, M1
Gorelick, DA; Gottheil, E; Mannelli, P; Patkar, AA; Peindl, K; Wu, LT1
Lee, SS; Merican, MI; Noordin, NM; Rahman, HA; Ramly, R1
Dolan, K; Larney, S1
Newman, RG1
Philibin, SD; Porter, JH; Vann, RE; Varvel, SA; Walentiny, DM; Wise, LE1
Baud, FJ; Chevillard, L; Mégarbane, B; Risède, P1
Gross, ER; Gross, GJ; Hsu, AK1
Bramness, J; Gossop, M; Lobmaier, P; Waal, H1
Lemesle, F; Nicola, W; Pierre Jonville-Béra, A1
Abbott, PJ1
Howland, RH1
Gossop, M; Katevoll, T; Kunøe, N; Lobmaier, PP; Waal, H1
Amato, L; Bargagli, AM; Davoli, M; Diecidue, R; Faggiano, F; Jarre, P; Perucci, CA; Salamina, G; Schifano, P; Vigna-Taglianti, F1
Holt, E1
Metzger, DS; Zhang, Y1
Krupitsky, E; O'Brien, CP; Woody, GE; Zvartau, E1
Amar, R; Casarella, J; Drexler, K; Fareed, A; Vayalapalli, S1
Goldman, D; Heinz, A; Ho, MK; Kaprio, J; Kreek, MJ; Li, MD; Munafò, MR; Tyndale, RF1
Milan-Lobo, L; Whistler, JL1
Gorelick, DA; Mannelli, P; Patkar, AA; Peindl, K; Tharwani, HM; Wu, LT1
Dodrill, CL; Helmer, DA; Kosten, TR1
Law, F; Melichar, J; O'Shea, J1
Craft, RM; Wakley, AA1
Morgan, RW; Nicholson, KL1
Bart, G2
Metzger, DS; Woody, GE1
Gorelick, DA; Mannelli, P; Patkar, AA; Peindl, K; Wu, LT1
Flynn, PM; Friedmann, PD; Frisman, LK; Gordon, M; Hall, E; Hoskinson, R; Kinlock, T; Knight, K; Knudsen, HK; O'Connell, DJ; Sacks, S; Schwartz, R; Shafer, MS; Stein, LA; Welsh, WN1
Bhatia, KS; Lee, T; Mannelli, P; Peindl, KS; Wu, LT1
Bisaga, A; Kosten, T; Nunes, EV; O'Connor, PG; Sigmon, SC; Woody, G1
Chisolm, MS; Jansson, LM; Jones, HE; Terplan, M1
Jovanović, T; Lazarević, D; Nikolić, G1
Banks, ML; Lunzer, MM; Negus, SS; Portoghese, PS; Rice, KC; Yekkirala, AS1
Law, F; Melichar, J; O'Shea, J; Praveen, KT1
Banks, ML; Negus, SS1
Stitzer, ML1
White, J1
Bennett, L; Donaldson, LF; Green, A; Kaul, A; Melichar, JK; Mullings, EL; Munafò, MR; Nutt, DJ; O'Shea, J; Sharma, E1
Hulse, GK; Reece, AS1
Ingram, SL; Lamberts, JT; Li, MH; Neubig, RR; Smith, CE; Traynor, JR1
Aghabiklooei, A; Ghoochani, A; Hassanian-Moghaddam, H; Mashayekhian, M; Nasouhi, S; Rahimi, M; Shadnia, S; Zamani, N1
Duffy, S; Glanville, JM; Godfrey, C; Hewitt, C; Martyn-St James, M; McCool, R; Neilson, M; Perry, AE1
Matthew-Simmons, F; Ritter, A1
Hoffman, RS; Kessler, BD1
Gregg, M; Martinez, L; Samaritan, G1
Bawor, M; Bonner, A; Daiter, J; Dennis, BB; Desai, D; Marsh, DC; Naji, L; Pare, G; Plater, C; Samaan, Z; Thabane, L; Varenbut, M; Worster, A1
Friedmann, PD; Park, TW1
Degenhardt, L; Farrell, M; Hall, W; Kimber, J; Larney, S1
Fürst, Z; Hosztafi, S1
Chatterjee, D; Jackson, H; Johnson, K; Mandell, K; Vanness, DJ1
Aghabiklooei, A; Hassanian-Moghaddam, H; Zamani, N1
Chalk, M; Lubran, R; Mark, TL; McCance-Katz, EF; Richardson, J1
Lu, Z; Majumdar, S; Pan, YX; Pasternak, GW; Rossi, GC; Xu, J1
Glanville, JM; Godfrey, C; Hewitt, C; Martyn-St James, M; Neilson, M; Perry, AE; Woodhouse, R1
Donnerstag, N; Lüthi, A; Mehlig, A; Raetz Bravo, A; Schneider, T; Taegtmeyer, A1
Maremmani, AG; Maremmani, I; Parrino, MW; Samuels, PN1
Dahmke, H; Kullak-Ublick, GA; Kupferschmidt, H; Weiler, S1
Cucciare, MA; Garrison-Diehn, C; Schultz, NR; Timko, C; Vittorio, L1
Binswanger, I; Blue-Howells, J; Clark, S; Finlay, AK; Frayne, SM; Harris, AH; McGuire, J; Oliva, E; Rosenthal, J; Smelson, D; Timko, C1
Bonilla, W; Flannery, M; Goldfeld, K; Gourevitch, MN; Johnson, CW; Laska, E; Lee, JD; Leibowitz, N; McDonald, RD; Rotrosen, J; Santana-Correa, N; Tofighi, B1
Bennett, D; Chandler, RK; Condon, T; Dunlap, LJ; Farabee, D; Finger, MS; Hillhouse, M; Kelly, SM; Laska, E; Lee, JD; McCollister, K; McDonald, RD; Mitchell, SG; O'Grady, KE; Schwartz, RP; Zarkin, GA1
Cabrera, EA; Lindgren, E; Miller, G; Volkow, ND; Wang, GJ; Wiers, CE1
Anderson, B; Bailey, G; Herman, D; Stein, M; Uebelacker, LA1
Klein, JW1
Ayanga, D; Kosten, TR; Shorter, D1
Alagoz, E; Gustafson, DH; Johnson, RA; Kornfield, R; Landucci, G; Mares, ML; McTavish, F; Pe-Romashko, K; Quanbeck, A; Shah, D; Thomas, C; Westergaard, RP1
Gryczynski, J; Kelly, SM; Mitchell, SG; O'Grady, KE; Schwartz, RP; Sharma, A1
Hulse, G; Kelty, E4
Griffin, BL; Stone, RH; Todd, TJ; Tran, TH; Vest, KM1
Chang, DC; Fairbairn, N; Klimas, J; Wood, E1
Desai, N; Kelly, MM; Quiñones, T; Reilly, E; Rosenheck, R1
Bagley, SM; Carney, BL; Hadland, SE1
Atreja, N; Duncan, M; Gore, M; Shah, A; Tai, KS1
Baijnath, S; Gopal, ND; Govender, T; Kruger, HG; Naicker, T; Pamreddy, A; Teklezgi, BG1
Alexander-Scott, N; Boss, R; Brinkley-Rubinstein, L; Clarke, J; Green, TC; Marshall, BDL; Rich, JD1
Azhar, G; Chen, C; Hempel, S; Maglione, MA; Maksabedian, E; Newberry, S; Raaen, L; Shahidinia, N; Shanman, RM; Shen, M1
Graham, DP; Kosten, TR; Nielsen, DA1
Quaye, AN; Ward, EN; Wilens, TE1
Bisaga, A; Campbell, AN; Crystal, S; Friedmann, PD; Johnson, KA; Levin, FR; Nunes, EV; Olfson, M; Pincus, HA; Remien, RH; Williams, AR1
Bagley, SM; Bernson, D; Land, T; Larochelle, MR; Liebschutz, JM; Stopka, TJ; Walley, AY; Wang, N; Xuan, Z1
Bao, YP; Blow, FC; Degenhardt, L; Farrell, M; Ilgen, M; Li, JQ; Liu, MX; Lu, L; Ma, J; Shi, J; Su, MF; Wang, RJ1
Alexander, GC; Saloner, B; Stoller, KB1
Blackney, KA; Edwards, DA; Kamdar, NV; Liu, CA1
Cotton, A; Elton, P; Irving, P; Jones, S; McNeill, J; Mohammed, F; Monk, R; Murphy, PN; Sharples, L; Wareing, M1
Aschenbrenner, DS1
Binswanger, IA; Fazel, S; Hellner, C; Larsson, H; Molero, Y; Zetterqvist, J1
Aggarwal, AK; Harrison, TK; Kornfeld, H; Lembke, A1
Haffajee, RL; Weintraub, E; Yang, YT1
Fauconneau, B; Favrelière, S; Lafay-Chebassier, C; Montastruc, F; Pérault-Pochat, MC; Quillet, A; Yéléhé-Okouma, M1
Clarke, JG; Gresko, SA; Martin, RA; Rich, JD1
Bagley, SM; Hadland, SE; Larochelle, MR; Levy, S; Rodean, J; Samet, JH; Silverstein, M; Zima, BT1
Broglio, K; Matzo, M1
Dehpour, AR; Fakhraei, N; Hashemizadeh, S; Javadian, N; Nili, F; Rahimi, N; Rahimian, R1
Binswanger, IA; Bowe, T; Finlay, AK; Harris, AHS; Smelson, D; Stimmel, MA; Timko, C; Yu, M1
Gordon, MS; Gryczynski, J; Jaffe, JH; Kelly, SM; Mitchell, MM; Mitchell, SG; O'Grady, KE; Schwartz, RP1
Bowe, TR; Burden, JL; Ellerbe, LS; Finlay, AK; Gupta, S; Harris, AHS; Rubinsky, A; Schmidt, EM; Timko, C; Wong, JJ1
Kaplan, L1
Ali, R; Hu, L; Marsden, J; Rush, AJ; Tai, B; Volkow, N1
Fanucchi, L; Korthuis, PT; Springer, SA1
McKee, SA; Moore, KE; Oberleitner, LMS; Reid, HH; Roberts, W; Smith, KMZ1
Heller, NM; Maher, DP; Walia, D1
Butler, F; Witt, L1
Hulse, G; Joyce, D; Kelty, E1
Barnett, BS; Suzuki, J; Ward, HB1
Barnes, DE; Marton, T; Wallace, A; Woolley, JD1
Barry, CL; Gollust, SE; Kennedy-Hendricks, A; Levin, J; McGinty, EE; Stone, E1
Rosenberg, L1
Aghaei, I; Bahramnejad, E; Dehpour, AR; Kazemi Roodsari, S; Rahimi, N1
Landau, R1
Dzau, VJ; Leshner, AI1
Duello, A; Green, L; Horn, P; Presnall, N; Rudder, T; Stringfellow, E; Winograd, RP; Wood, C1
Allan, GM; Dugré, N; Finley, CR; Garrison, S; Kolber, MR; Korownyk, C; Lindblad, AJ; Perry, D; Thomas, B; Ting, R; Ton, J; Vandermeer, B; Yang, PR1
Banken, R; Kumar, VM; Otuonye, IS; Pearson, SD1
Choi, S; Healy, S; Neighbors, CJ; Shapoval, L; Sun, T; Yerneni, R1
Glance, JB; Gopalan, P; Kmiec, J; Spada, M1
Bridgeman, PJ; Koehl, JL; Zimmerman, DE1
Katz, E; Towers, CV; Visconti, K; Weitz, B1
Lin, MP; Manini, AF; Richardson, LD; Shastry, S1
Bell, J; Strang, J1
Chemi, C; Dickson, V; Lee, JD; Suhail-Sindhu, S; Tofighi, B; Williams, AR1
Camenga, DR; Colon-Rivera, HA; Muvvala, SB1
Alam, F; Dhadley, S; Roberts, P; Townley, J; Webster, R; Wright, N1
Gold, MS; Oesterle, TS; Rummans, TA; Thusius, NJ1
Ashford, RD; Bergman, BG; Kelly, JF1
Badolato, R; Flannery, M; Garment, AR; Giftos, J; Lee, JD; McDonald, RD; Tofighi, B; Velasquez, M; Vittitow, A1
Coffa, D; Snyder, H1
Bagley, SM; Bernson, D; Hadland, SE; Land, T; Larochelle, MR; Patel, A; Samet, JH; Silverstein, M; Walley, AY; Wang, N; Xuan, Z1
Byrd, DJ; Campbell, TB; Clarke, TJ; Jones, CM; McCance-Katz, EF; Ohuoha, C1
Brown, JN; Elias, AM; Pepin, MJ1
Blanco, C; Volkow, ND1
Brezel, ER; Fox, AD; Powell, T1
Felix, C; Olsen, Y; Sharfstein, JM1
Johnson, JA; Liebschutz, JW; Martin, B; Montgomery, MW; Mosquera, M; Price, CD; Robinson, D; Schnipper, JL; Solomon, DA; Suzuki, J; Weiss, RD1
Banks, ML; Negus, SS; Townsend, EA1
Bergeria, CL; Dunn, KE; Hobelmann, JG; Huhn, AS; Oyler, GA; Strickland, JC; Umbricht, A1
Agus, D; Fingerhood, M; Krawczyk, N; Lyons, BC; Mojtabai, R; Saloner, B; Stuart, EA; Weiner, JP1
Babakhanlou-Chase, H; Bernson, D; Land, T; Larochelle, MR; Li, Y; Lodi, S; Walley, AY1
Fuehrlein, B; Jaeger, S1
Hulse, G; Joyce, D; Kelty, E; Preen, DB1
Altice, FL; Bromberg, DJ; Nyhan, K; Refsland, BM; Stanojlović, M; Viera, A; Whittaker, S1
Wakeman, SE1
Andraka-Christou, B; Atkins, D; Madeira, J; Silverman, RD1
Fine, M; Herscher, M; Hirt, L; Navalurkar, R; Wang, L1
Burden, J; Codell, NK; Drexler, K; Dungan, MT; Gordon, AJ; Hagedorn, H; Hawkins, EJ; Mhatre-Owens, A1
Joo, H; KuKanich, B; KuKanich, K; Locuson, CW; Rankin, DC1
Chalhoub, RM; Kalivas, PW1
Bachhuber, MA; Barry, CL; Kennedy-Hendricks, A; McGinty, EE; Stone, E1
Acevedo-Mackey, D; Acharjee, N; Akhtar, K; Al-Buriahi, MS; Amandi, A; An, Y; Anjum, NA; Asgari, Q; Badiei, B; Baez Vasquez, AY; Bagley, GD; Bahreini, MS; Bajelan, S; Baluja, MQ; Barbieri, MA; Batalha, MA; Bettiol, H; Bhattarai, U; Biset, JC; Bjerg, M; Björnsson, BT; Boag, AM; Borthwick, MS; Boukhris, I; Bragança, MLBM; Breves, JP; Britz-McKibbin, P; Broaddus, RR; Burnell, JE; Camargo, CA; Campo, M; Carlsen, KL; Catchpole, B; Cavalli, L; Chai, C; Chanakya, HN; Chang, AYH; Chantada, A; Chen, W; Chen, X; Chen, Y; Cheng, ZL; Chenoweth, DA; Chhetri, S; Coelho, CCNDS; Coker, ES; Cole, MA; Coniglio, A; Connor, TR; Corbishley, A; D'Arienzo, M; da Silva, AAM; Dai, Y; de Oliveira, BR; Dignac, MF; Dong, A; Dottino, JA; Duo, J; Einarsdottir, IE; Ekanayake, EMDNK; El Fels, L; El Hayany, B; El Shahawy, O; Elliott, RJR; Fabrizi, E; Farkas, K; Fellman, B; Fenoglio, D; Ferrario, M; Flögel, F; Fujiogi, M; Gamage, BD; Ganson, KT; Gao, X; Gärtner, S; Gautam, A; Gautam, S; Gaze, WH; Gosse, JA; Graham, DW; Graham, PA; Guastella, G; Guerrero, S; Gul, M; Guo, B; Guo, X; Gupta, VK; Hafidi, M; Halland, A; Han, W; Hardisty, M; Hasegawa, K; Hess, ST; Heydari, R; Hillary, LS; Holm, R; Huang, L; Jaleh, B; Jayasundara, JASB; Ji, X; Jiang, L; Jones, DL; Kac, G; Kebaili, I; Kelley, JB; Kelum, SHP; Kennedy, LJ; Khan, NA; Khazalpour, S; Khuntia, HK; Kinney, MS; Kommedal, Ø; Koomhin, P; Krawczyk, N; Kæstel, T; Lakmal, MAC; Li, H; Li, K; Li, R; Li, S; Li, W; Li, X; Li, Y; Liang, L; Lin, Y; Lippo, E; Liu, B; Liu, F; Liu, J; Liu, X; Liu, Y; Lodha, D; Loose, DS; López-Meza, P; Lu, F; Lu, KH; Lu, Y; Luo, Y; Ma, B; Malham, SK; Masood, A; Matan, N; McCormick, SD; McDonald, JE; McKenzie, LJ; Melendez, BD; Mikaeili, F; Mir, IR; Mirjalili, MH; Moreno, KP; Moura, IB; Müller, S; Nagata, JM; Nasri, A; Nasrollahzadeh, M; Navarro-Jiménez, E; Nie, E; Nielsen, CU; Nielsen, S; Nøhr, MK; Obeng, B; Odetayo, AA; Ortiz-Barrios, M; Ozgen, C; Pan, X; Parisi, ML; Paskavitz, AL; Patel, AK; Pedersen, M; Pontarollo, N; Potts, CM; Price, C; Pu, Y; Quénéa, K; Rahimi Khonakdari, M; Rather, BA; Raut, P; Regish, AM; Reible, DD; Rezadoost, H; Rizzati, M; Roviello, GN; Roviello, V; Rumpel, C; Sang, J; Sangroula, S; Saraiva, MDCP; Sarker, A; Sayyed, MI; Segoshi, A; Sehar, Z; Shao, X; Shaw, D; Shaw, L; Shekhawat, NS; Shim, JK; Shokouhimehr, M; Short, A; Soliman, PT; Songsamoe, S; Springer-Miller, RH; Stenstad, T; Strobl, E; Sun, R; Syme, H; Thai, L; Tian, G; Tofighi, B; Tonguc, B; Tuyiringire, D; Ulaganathan, N; Ulvestad, E; Varacca, A; Vergalli, S; Verma, DK; Villmones, HC; Wang, D; Wang, H; Wang, J; Wang, L; Wang, M; Wang, S; Wang, Y; Wang, Z; Weedon-Fekjær, H; Weller, SR; West, BE; Wilcox, MH; Wu, W; Wufuer, R; Xia, S; Xiang, H; Xu, H; Yan, L; Yang, RK; Yang, Y; Yates, MS; Ye, Q; Yin, H; Yin, Y; Yuan, Y; Yucesan, M; Yue, W; Zeng, W; Zhang, C; Zhang, D; Zhang, H; Zhang, L; Zhang, Q; Zhang, Y; Zhou, B; Zhou, Y; Zhu, Y; Zhu, Z1
Ameli, O; Azocar, F; Chaisson, CE; Crown, WH; Larochelle, MR; McPheeters, JT; Sanghavi, DM; Wakeman, SE1
Ayers, C; Chan, B; Freeman, M; Kansagara, D; Kondo, K; Korthuis, PT; Paynter, R1
Andraka-Christou, B; Attermann, J; Beck, AJ; Buche, J; Cupito, A; Haffajee, RL1
Andraka-Christou, B; Atkins, D1
Berke, K; Cho, P; Comroe, A; Crauer, B; Fitzgerald, AH; Gonzalez, SE; Jensen, G; Klocke, EE; Komp, M; KuKanich, B; KuKanich, K; Mason, D; Orchard, R; Rankin, DC; Upchurch, DA1
Biondi, BE; Cioe, K; Easly, R; Simard, A; Springer, SA; Zheng, X1
Allen, J; Beauchamp, GA; Boateng, N; Burmeister, DB; Esposito, SB; Laubach, LT; Lauber, P; Roth, P; Shaak, S; Yazdanyar, A1
Baron, CA; Blinova, K; Johannesen, L; Patel, D; Randolph, AL; Ren, M; Sheng, J; Strauss, DG; Thiebaud, N; Tran, PN; Volpe, DA; Wu, M; Wu, WW1
Donelan, CJ; Evans, EA; Hayes, E; Potee, RA; Schwartz, L1
Farnaghi, F; Gholami, N; Hassanian-Moghaddam, H; McDonald, R; Saberi, M; Zamani, N1
Crawford, TN; Fischer, KB; Gainer, DM; Wright, MD1
Basaraba, C; Bisaga, A; Brooks, DJ; Choi, CJ; Levin, FR; Mahony, AL; Mariani, JJ; Naqvi, N; Pavlicova, M1
Baratta, JL; Ferd, P; Patel, N; Schwenk, ES; Torjman, MC; Viscusi, ER1
Bhat, NR; Bierut, LJ; Borodovsky, JT; Grucza, RA; Mintz, CM; Presnall, N; Xu, KY1
Cho, P; Fitzgerald, AH; Komp, MS; KuKanich, B; KuKanich, K; Locuson, CW; Rankin, DC1
Bergeria, CL; Dunn, KE; Huhn, AS; Nayak, SM; Strain, EC1
Adekoya, P; Gulati, A; Hunter, C; Jones, MR; Kaye, AD; Kaye, AM; Kuppalli, S; Orhurhu, V; Seth, R; Urits, I1
Bachireddy, C; Terplan, M1
Freeman, PR; Huang, Z; Oser, C; Sohn, M; Talbert, JC1
Campbell, ANC; Choo, TH; Haenlein, P; Lee, JD; Nunes, EV; Pavlicova, M; Rotrosen, J; Scodes, J; Shulman, M; Tofighi, B; Wai, J1
Ahmed, S; Galbis-Reig, D; Hybki, B; Penders, T; Stanciu, C1
Bain, PA; Carrero, ND; Chatterjee, A; Li, R; McLaughlin, MF1
Assoumou, SA; Barocas, J; Chatterjee, A; Hadland, SE; Linas, BP; Morgan, JR; Murphy, SM; Walley, AY1
Adam, GP; Balk, EM; Becker, SJ; Danko, KJ; Helseth, SA; Saldanha, IJ; Scott, K; Steele, DW1
Cao, DN; Li, F; Li, J; Wu, N1
Bandara, S; Barry, CL; Kennedy-Hendricks, A; Merritt, S; Saloner, B1
Nalven, T; Schick, MR; Spillane, NS; Weyandt, LL1
Bierut, LJ; Grucza, RA; Hartz, SM; Mintz, CM; Presnall, NJ; Sahrmann, JM; Xu, KY1
Ahrens, K; Allen, L; Austin, A; Barnes, AJ; Burns, M; Chang, CH; Clark, S; Cole, E; Crane, D; Cunningham, P; Donohue, JM; Gordon, AJ; Idala, D; Jarlenski, MP; Junker, S; Kennedy, S; Kim, JY; Lanier, P; Mauk, R; McDuffie, MJ; Mohamoud, S; Pauly, N; Sheets, L; Talbert, J; Tang, L; Zivin, K1
Kalin, NH1
Komrowski, MD; Sekhri, NK1
Light, T; Madden, EF; Prevedel, S; Sulzer, SH1
Hochheimer, M; Unick, GJ1
Allen, LR; Manini, AF; Nobel, I; Richardson, LD; Shastry, S; Vidal, K1
Laks, J; Peterkin, A; Weinstein, ZM1
Bromberg, DJ; Karamouzian, M; Pilarinos, A1
Ashmead, R; Bailey, E; Bickert, T; Bonny, AE; Doogan, NJ; Mack, A; Schmidt, S; Tossone, K; Zhang, P1
Chaisson, CE; Ciemins, E; LaRochelle, MR; Linas, BP; Morgan, JR; Quinn, EK; Stempniewicz, N; Walley, AY; White, LF1
Amaducci, AM; Beauchamp, GA; Hanisak, JL; Koons, AL; Laskosky, J; Maron, BM; McLoughlin, TM1
Fradkin, D; Kameg, B; Lepore, M1
Beck, M; Kay, A; Shmuts, R1
Digbeu, B; Kuo, YF; Priyadarshni, S; Raji, MA; Yu, X1
Anderson-Harper, R; Duello, A; Gochez-Kerr, T; Lohmann, B; Miles, J; Richardson, K; Winograd, RP; Wood, CA1
Biondi, BE; Schlossberg, EF; Shaw, A; Springer, SA; Vander Wyk, B1
Dromgoole, D; Ghanem, N; Hussein, A; Jermyn, RT1
Douros, A; Farhat, I; Lim, J; Panagiotoglou, D1
Anguiano, V; Joudrey, PJ; Kolak, M; Lin, Q; Paykin, S; Wang, EA1
Anselin, L; Kolak, M; Lin, Q; Pollack, H; Schneider, J; Taylor, B; Watts, B1
Bierut, LJ; Grucza, RA; Mintz, CM; Presnall, N; Xu, KY1
Angermaier, G; Carswell, N; Castaneda, C; Delgado, F1
Abare, M; Chyorny, A; Olson, M; Wilhelm-Leen, E; Will, J1
Berro, LF; Freeman, KB; Rowlett, JK; Talley, JT; Zamarripa, CA1
Abdel-Mohsen, M; Azzoni, L; Fair, M; Giron, LB; Hiserodt, E; Lalley-Chareczko, L; Lynn, K; Montaner, LJ; Mounzer, K; Trooskin, S; Vadrevu, S; Zhao, L1
Andraka-Christou, B; Buche, J; Haffajee, RL; Page, C; Schoebel, V1
Di Paola, A; Lier, AJ; Seval, N; Springer, SA; Vander Wyk, B1
Agius, E; Kollin, R; Lee, G; Madden, EF; Pasman, E; Resko, SM; Rodriguez, B1
Blanco, C; Compton, WM; Hodges, K; Jones, CM; Ling, SM; Losby, JL; Shoff, C1
Bolton, J; Hoang, H; Laiteerapong, N; Marsh, J; Murugesan, M; Nocon, R; Peterson, L; Pollack, H1
Acuña, AM; Leyrer-Jackson, JM; Olive, MF1
Cheng, A; Garrity, K; Hey, SP; Lee, JD; Lindquist, K; Malone, M; McDonald, R; McNeely, J; Pace, N; Roberts, T; Schatz, D; Sugarman, A; Tofighi, B; Vittitow, A; Williams, O1
Díaz, I; Luo, SX; Nunes, EV; Rotrosen, J; Rudolph, KE; Williams, NT1
Batki, SL; Baxley, C; Becker, W; Borsari, B; Herbst, E; Manuel, JK; Pennington, D; Reavis, JV; Seal, K1
Konakanchi, JS; Sethi, R1
Balise, RR; Brandt, L; Castillo, F; Feaster, DJ; Hu, MC; Liu, Y; Luo, SX; Nunes, EV; Odom, GJ1
Bisaga, A; Dresser, L; Fishman, M; Ghitza, UE; Greiner, MG; Hamilton, A; Hefner, K; Ho, R; Jelstrom, E; Nunes, EV; Opara, O; Potter, K; Rotrosen, J; Scheele, C; Shulman, M; Tafessu, HM; Voronca, DC1
Batty, E; Booty, MD; Harp, K; Knudsen, HK; Oser, CB; Staton, M1
Cox, KM; Doyle, M; Marsch, LA; McLeman, BM; Murray, OB; Ryer, J; Saunders, EC; Watts, D1
Cornett, EM; Edinoff, AN; Flanagan, CJ; Jackson, ED; Kaye, AD; Kaye, AM; Pearl, NZ; Sinnathamby, ES; Wenger, DM1
Haigney, MCP; Kao, DP; Kleiman, RB; Klein, M; Krantz, MJ; Rudo, TJ; Stockbridge, N1
Berger, NA; Davis, PB; Kaelber, DC; Volkow, ND; Wang, L; Xu, R1
Balise, RR; Castillo, F; Feaster, DJ; Hu, MC; Liu, Y; Luo, SX; Nunes, EV; Rotrosen, J; Saxon, AJ; Weiss, RD1

Reviews

107 review(s) available for methadone and naltrexone

ArticleYear
UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Pharmacology & therapeutics, 2005, Volume: 106, Issue:1

    Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic

2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[The treatment of drug-dependence (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1978, Jun-27, Volume: 67, Issue:26

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Alcoholism; Amphetamines; Barbiturates; Communication; Drug Tolerance; Female; Halfway Houses; Humans; Male; Methadone; Middle Aged; Morphine Dependence; Motivation; Naltrexone; Personality Disorders; Psychotherapy; Social Control, Formal; Social Control, Informal; Substance-Related Disorders

1978
Methadone maintenance and narcotic blocking drugs. Appendix.
    The International journal of the addictions, 1977, Volume: 12, Issue:7

    Topics: Administration, Oral; Cyclazocine; Drug Tolerance; Heroin Dependence; Humans; Injections, Subcutaneous; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Research; Substance Withdrawal Syndrome

1977
Disposition of narcotics and narcotic antagonists.
    Annals of the New York Academy of Sciences, 1976, Volume: 281

    Topics: Animals; Biotransformation; Chickens; Dogs; Guinea Pigs; Haplorhini; Humans; Male; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics; Pupil; Rabbits; Rats; Time Factors

1976
[Clonidine-naltrexone: a new technic for the detoxification of opiate addicts].
    Medicina clinica, 1990, Nov-10, Volume: 95, Issue:16

    Topics: Clonidine; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome

1990
Drugs of abuse--opiates.
    The Western journal of medicine, 1990, Volume: 152, Issue:5

    Topics: Central Nervous System; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Narcotics; Opioid-Related Disorders; Primary Health Care; Receptors, Opioid

1990
Clinical toxicology of drugs used in the treatment of opiate dependency.
    Clinics in laboratory medicine, 1990, Volume: 10, Issue:2

    Topics: Buprenorphine; Clonidine; Humans; Methadone; Methadyl Acetate; Naltrexone; Opioid-Related Disorders

1990
Clonidine and the treatment of the opiate withdrawal syndrome.
    Drug and alcohol dependence, 1988, Volume: 21, Issue:3

    Topics: Clonidine; Humans; Hypotension; Methadone; Naltrexone; Narcotics; Substance Withdrawal Syndrome

1988
Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
    Acta psychiatrica Scandinavica. Supplementum, 1986, Volume: 327

    Topics: Adrenergic Fibers; Animals; Antidepressive Agents, Tricyclic; Brain; Clinical Trials as Topic; Clonidine; Dextropropoxyphene; Drug Therapy, Combination; Heroin Dependence; Humans; Locus Coeruleus; Methadone; Morphine; Naltrexone; Narcotics; Norepinephrine; Rats; Substance Withdrawal Syndrome

1986
Behavioral pharmacology of buprenorphine.
    Drug and alcohol dependence, 1985, Volume: 14, Issue:3-4

    Topics: Adult; Animals; Buprenorphine; Conditioning, Operant; Eating; Heroin Dependence; Humans; Macaca; Male; Methadone; Morphinans; Naltrexone; Opioid-Related Disorders; Reinforcement, Psychology; Self Administration

1985
[Narcotic withdrawal syndrome. Therapeutic methods].
    Revista clinica espanola, 1982, Oct-15, Volume: 167, Issue:1

    Topics: Acupuncture Therapy; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Analgesia; Brain; Central Nervous System Agents; Clonidine; Endorphins; Humans; Methadone; Naloxone; Naltrexone; Narcotics; Receptors, Opioid; Substance Withdrawal Syndrome; Substance-Related Disorders

1982
The role of narcotic antagonists in the rehabilitation of opiate addicts: a review of naltrexone.
    The American journal of drug and alcohol abuse, 1980, Volume: 7, Issue:1

    Topics: Clinical Trials as Topic; Double-Blind Method; Endorphins; Humans; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Receptors, Opioid

1980
New insights and treatments: opiate withdrawal and cocaine addiction.
    Clinical therapeutics, 1984, Volume: 7, Issue:1

    Topics: Brain Chemistry; Clonidine; Cocaine; Dopamine; Humans; Methadone; Naltrexone; Norepinephrine; Substance Withdrawal Syndrome; Substance-Related Disorders

1984
Managing illicit drug use. A practical guide.
    Drugs, 1994, Volume: 47, Issue:3

    Topics: Buprenorphine; Counseling; Disulfiram; Humans; Methadone; Methadyl Acetate; Naltrexone; Psychotherapy; Self-Help Groups; Substance Abuse Treatment Centers; Substance-Related Disorders

1994
Opiate detoxification protocols. A clinical manual.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1993, Volume: 5, Issue:1

    Topics: Administration, Cutaneous; Clinical Protocols; Clonidine; Codeine; Female; Humans; Male; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Psychiatric Status Rating Scales; Receptors, Opioid; Substance Withdrawal Syndrome

1993
Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
    The Psychiatric clinics of North America, 1993, Volume: 16, Issue:1

    Topics: Animals; Buprenorphine; Clonidine; Humans; Locus Coeruleus; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1993
What is important in drug misuse treatment?
    Lancet (London, England), 1996, Feb-10, Volume: 347, Issue:8998

    Topics: Buprenorphine; Clonidine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome; Substance-Related Disorders; United Kingdom

1996
[Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
    Der Internist, 1996, Volume: 37, Issue:10

    Topics: Alcoholism; Delayed-Action Preparations; Follow-Up Studies; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Recurrence; Treatment Outcome

1996
Role of maintenance treatment in opioid dependence.
    Lancet (London, England), 1999, Jan-16, Volume: 353, Issue:9148

    Topics: Humans; Methadone; Naltrexone; Narcotics; Opioid-Related Disorders

1999
Pharmacologic treatment of heroin-dependent patients.
    Annals of internal medicine, 2000, Jul-04, Volume: 133, Issue:1

    Topics: Analgesics, Opioid; Buprenorphine; Counseling; Heroin Dependence; Humans; Mental Disorders; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Physician's Role; Substance Withdrawal Syndrome

2000
Safe approaches to treating drug addiction.
    The Practitioner, 2000, Volume: 244, Issue:1610

    Topics: Drug Overdose; Family Practice; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Sorption Detoxification; Substance-Related Disorders

2000
[Contemporary methods in pharmacotherapy in the opiate dependent treatment].
    Przeglad lekarski, 2000, Volume: 57, Issue:10

    Topics: Adrenergic alpha-Agonists; Buprenorphine; Clonidine; Heroin Dependence; Humans; Inactivation, Metabolic; Methadone; Naltrexone; Narcotic Antagonists; Narcotics

2000
The physical and psychosocial consequences of opioid addiction: an overview of changes in opioid treatment.
    The Australian and New Zealand journal of mental health nursing, 2000, Volume: 9, Issue:2

    Topics: Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome

2000
Pharmacotherapy of addictions.
    Nature reviews. Drug discovery, 2002, Volume: 1, Issue:9

    Topics: Alcoholism; Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Substance-Related Disorders

2002
Pharmacologic treatments for heroin and cocaine dependence.
    The American journal on addictions, 2003, Volume: 12, Issue:s2

    Topics: Buprenorphine; Clonidine; Cocaine-Related Disorders; Comorbidity; Heroin Dependence; Humans; Mental Disorders; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics

2003
Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
    Issue brief (Health Policy Tracking Service), 2002, Dec-31

    Topics: Alcohol Deterrents; Alcoholism; Analgesics, Opioid; Buprenorphine; Drug Therapy; Humans; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Substance-Related Disorders; United States

2002
Pharmacological treatments for substance use disorders.
    Journal of psychosocial nursing and mental health services, 2004, Volume: 42, Issue:8

    Topics: Adrenergic beta-Antagonists; Alcohol Deterrents; Anti-Anxiety Agents; Benzodiazepines; Buprenorphine; Disulfiram; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neurobiology; Neuropharmacology; Psychopharmacology; Substance Withdrawal Syndrome; Substance-Related Disorders

2004
Pharmacotherapy treatment in substance-dependent correctional populations: a review.
    Substance use & misuse, 2005, Volume: 40, Issue:13-14

    Topics: Humans; Methadone; Naltrexone; Narcotic Antagonists; Prisoners; Substance-Related Disorders

2005
Opiate addiction in China: current situation and treatments.
    Addiction (Abingdon, England), 2006, Volume: 101, Issue:5

    Topics: Buprenorphine; China; Clonidine; Drugs, Chinese Herbal; HIV Infections; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Sympatholytics

2006
Contingency management for treatment of substance abuse.
    Annual review of clinical psychology, 2006, Volume: 2

    Topics: Alcoholism; Behavior Therapy; Combined Modality Therapy; Counseling; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Patient Compliance; Reinforcement, Psychology; Substance-Related Disorders; Token Economy; Treatment Outcome

2006
Treatment of alcohol and other drug dependence.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:11 Suppl 2

    Topics: Alcoholism; Behavior, Addictive; Comorbidity; Humans; Methadone; Naltrexone; Psychotherapy; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome

2007
A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?
    European addiction research, 2009, Volume: 15, Issue:2

    Topics: Buprenorphine; Heroin Dependence; HIV Infections; Humans; International Cooperation; Methadone; Naltrexone; Narcotic Antagonists; Patient Care; Prisoners; Prisons

2009
The pharmacological treatment of opioid addiction--a clinical perspective.
    European journal of clinical pharmacology, 2010, Volume: 66, Issue:6

    Topics: Adrenergic Agonists; Analgesics, Opioid; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Social Support; Substance Withdrawal Syndrome

2010
A review of the community reinforcement approach in the treatment of opioid dependence.
    Journal of psychoactive drugs, 2009, Volume: 41, Issue:4

    Topics: Adult; Female; Humans; Male; Methadone; Naltrexone; Opioid-Related Disorders; Psychotherapy; Reinforcement, Psychology; Therapy, Computer-Assisted

2009
Drug treatment as HIV prevention: expanding treatment options.
    Current HIV/AIDS reports, 2010, Volume: 7, Issue:4

    Topics: Alcoholism; Buprenorphine; Clinical Protocols; Drug Users; Health Promotion; HIV Infections; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Risk Reduction Behavior; Risk-Taking; Substance Abuse, Intravenous; Substance-Related Disorders

2010
Heroin anticraving medications: a systematic review.
    The American journal of drug and alcohol abuse, 2010, Volume: 36, Issue:6

    Topics: Buprenorphine; Heroin; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome

2010
Breaking barriers in the genomics and pharmacogenetics of drug addiction.
    Clinical pharmacology and therapeutics, 2010, Volume: 88, Issue:6

    Topics: Genetic Testing; Genetic Variation; Genomics; Humans; Methadone; Naltrexone; Pharmacogenetics; Substance-Related Disorders

2010
Prescription pain medication dependence.
    The American journal of psychiatry, 2011, Volume: 168, Issue:5

    Topics: Analgesics; Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Pain; Prescription Drugs; Substance-Related Disorders

2011
Opioid dependence.
    BMJ clinical evidence, 2009, Jul-24, Volume: 2009

    Topics: Analgesics, Opioid; Buprenorphine; Evidence-Based Medicine; Heroin Dependence; Humans; Incidence; Methadone; Naltrexone; Opioid-Related Disorders

2009
Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.
    Current drug abuse reviews, 2012, Volume: 5, Issue:1

    Topics: Biological Availability; Buprenorphine; Chemistry, Pharmaceutical; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome

2012
Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.
    The American journal of drug and alcohol abuse, 2012, Volume: 38, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clinical Protocols; Clonidine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome

2012
Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.
    Addiction (Abingdon, England), 2013, Volume: 108, Issue:2

    Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Risk Assessment; Risk Factors; Treatment Outcome

2013
Maintenance medication for opiate addiction: the foundation of recovery.
    Journal of addictive diseases, 2012, Volume: 31, Issue:3

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Long-Term Care; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome

2012
Medications development for opioid abuse.
    Cold Spring Harbor perspectives in medicine, 2013, Jan-01, Volume: 3, Issue:1

    Topics: Analgesics, Opioid; Buprenorphine; Choice Behavior; Endocannabinoids; Evidence-Based Medicine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neuroglia; Opioid-Related Disorders; Receptors, Opioid, mu; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Treatment Outcome

2013
Pharmacological interventions for drug-using offenders.
    The Cochrane database of systematic reviews, 2013, Dec-19, Issue:12

    Topics: Adult; Buprenorphine; Criminals; Female; Heroin; Humans; Male; Methadone; Naltrexone; Narcotics; Randomized Controlled Trials as Topic; Substance-Related Disorders

2013
Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders.
    Rhode Island medical journal (2013), 2014, Oct-01, Volume: 97, Issue:10

    Topics: Acamprosate; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Directive Counseling; Disulfiram; Humans; Methadone; Naltrexone; Narcotic Antagonists; Practice Patterns, Physicians'; Substance-Related Disorders; Taurine; United States

2014
[Therapy in heroin addiction].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2014, Volume: 16, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Analgesics, Opioid; Buprenorphine; Euphoria; Heroin; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment

2014
Pharmacological interventions for drug-using offenders.
    The Cochrane database of systematic reviews, 2015, Jun-02, Issue:6

    Topics: Adult; Buprenorphine; Crime; Criminals; Female; Heroin; Humans; Male; Methadone; Naltrexone; Narcotics; Opiate Substitution Treatment; Randomized Controlled Trials as Topic; Substance-Related Disorders

2015
Retention in medication-assisted treatment for opiate dependence: A systematic review.
    Journal of addictive diseases, 2016, Volume: 35, Issue:1

    Topics: Behavior Therapy; Buprenorphine; Heroin; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome

2016
A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2016, Volume: 11, Issue:3

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2016
Neuroimaging the Effectiveness of Substance Use Disorder Treatments.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2016, Volume: 11, Issue:3

    Topics: Clinical Trials as Topic; Cognitive Behavioral Therapy; Craving; Humans; Methadone; Naltrexone; Neurofeedback; Neuroimaging; Substance-Related Disorders; Treatment Outcome

2016
Pharmacotherapy for Substance Use Disorders.
    The Medical clinics of North America, 2016, Volume: 100, Issue:4

    Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2016
Update on pharmacotherapy for treatment of opioid use disorder.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:17

    Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Combined Modality Therapy; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome

2016
Update on Barriers to Pharmacotherapy for Opioid Use Disorders.
    Current psychiatry reports, 2017, Volume: 19, Issue:6

    Topics: Analgesics, Opioid; Buprenorphine; Health Services Accessibility; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; United States

2017
A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls.
    Drugs, 2017, Volume: 77, Issue:11

    Topics: Administration, Oral; Administration, Sublingual; Buprenorphine; Drug Implants; Female; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies

2017
Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Pharmacotherapy, 2017, Volume: 37, Issue:7

    Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome

2017
Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.
    Pediatrics in review, 2018, Volume: 39, Issue:1

    Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Clinical Protocols; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care

2018
Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review.
    Journal of substance abuse treatment, 2018, Volume: 89

    Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2018
Opioid Use Disorders: Perioperative Management of a Special Population.
    Anesthesia and analgesia, 2018, Volume: 127, Issue:2

    Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Drug Tolerance; Humans; Interdisciplinary Communication; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Patient Discharge; Patient-Centered Care; Perioperative Care

2018
Developing an opioid use disorder treatment cascade: A review of quality measures.
    Journal of substance abuse treatment, 2018, Volume: 91

    Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome

2018
Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.
    Molecular psychiatry, 2019, Volume: 24, Issue:12

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Drug Overdose; Female; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Risk

2019
Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
    Anesthesiology clinics, 2018, Volume: 36, Issue:3

    Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Pain Management; Perioperative Care

2018
CE: Acute Pain Management for People with Opioid Use Disorder.
    The American journal of nursing, 2018, Volume: 118, Issue:10

    Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Nurse's Role; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Palliative Care; Substance Withdrawal Syndrome

2018
Pharmacotherapy for opioid addiction in community corrections.
    International review of psychiatry (Abingdon, England), 2018, Volume: 30, Issue:5

    Topics: Buprenorphine; Criminal Law; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons

2018
Medications for Treatment of Opioid Use Disorder among Persons Living with HIV.
    Current HIV/AIDS reports, 2019, Volume: 16, Issue:1

    Topics: Buprenorphine; HIV Infections; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Treatment Outcome

2019
Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review.
    Journal of substance abuse treatment, 2019, Volume: 99

    Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Randomized Controlled Trials as Topic; Recidivism; Risk-Taking

2019
Medication Treatment For Substance Abuse.
    Health affairs (Project Hope), 2019, Volume: 38, Issue:4

    Topics: Adult; Buprenorphine; Female; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Patient Compliance; Patient Safety; Quality of Life; Risk Assessment; Severity of Illness Index; Substance-Related Disorders; Treatment Outcome; United States

2019
Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery.
    International journal of obstetric anesthesia, 2019, Volume: 39

    Topics: Analgesia, Patient-Controlled; Buprenorphine; Cesarean Section; Female; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Pain, Postoperative; Pregnancy; Pregnancy Complications

2019
Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews.
    Canadian family physician Medecin de famille canadien, 2019, Volume: 65, Issue:5

    Topics: Analgesics, Opioid; Buprenorphine; Counseling; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care; Randomized Controlled Trials as Topic; Systematic Reviews as Topic

2019
A Summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council.
    Journal of managed care & specialty pharmacy, 2019, Volume: 25, Issue:6

    Topics: Analgesics, Opioid; Buprenorphine; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Methadone; Models, Economic; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Policy; Treatment Outcome; United States

2019
Consideration of opioid agonist treatment in a pregnant adolescent: A case report and literature review.
    Substance abuse, 2020, Volume: 41, Issue:2

    Topics: Adolescent; Ambulatory Care; Analgesics, Opioid; Buprenorphine; Child, Foster; Female; Humans; Lost to Follow-Up; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Pregnancy in Adolescence

2020
Medications for management of opioid use disorder.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2019, Jul-18, Volume: 76, Issue:15

    Topics: Analgesics, Opioid; Buprenorphine; Drug Prescriptions; Evidence-Based Medicine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders

2019
Medication Treatment of Opioid Use Disorder.
    Biological psychiatry, 2020, 01-01, Volume: 87, Issue:1

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders

2020
Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks.
    Journal of studies on alcohol and drugs, 2019, Volume: 80, Issue:4

    Topics: Adolescent; Adolescent Behavior; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2019
Medication-Assisted Treatment for Opioid-Use Disorder.
    Mayo Clinic proceedings, 2019, Volume: 94, Issue:10

    Topics: Algorithms; Buprenorphine; Decision Trees; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2019
Opioid Use Disorder: Medical Treatment Options.
    American family physician, 2019, 10-01, Volume: 100, Issue:7

    Topics: Analgesics, Opioid; Buprenorphine; Chronic Disease; Evidence-Based Medicine; Female; Humans; Male; Mass Screening; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy

2019
Adjunctive memantine for opioid use disorder treatment: A systematic review.
    Journal of substance abuse treatment, 2019, Volume: 107

    Topics: Analgesics, Opioid; Buprenorphine; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Memantine; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Outcome Assessment, Health Care; Substance Withdrawal Syndrome

2019
Medications Development for Treatment of Opioid Use Disorder.
    Cold Spring Harbor perspectives in medicine, 2021, 01-04, Volume: 11, Issue:1

    Topics: Analgesics, Opioid; Buprenorphine; Choice Behavior; Drug Development; Evidence-Based Medicine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Receptors, Opioid, mu; Self Administration; Substance Withdrawal Syndrome; Treatment Outcome

2021
Buprenorphine initiation to treat opioid use disorder in emergency rooms.
    Journal of the neurological sciences, 2020, Apr-15, Volume: 411

    Topics: Analgesics, Opioid; Buprenorphine; Emergency Service, Hospital; Humans; Methadone; Naltrexone; Opioid-Related Disorders; United States

2020
Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality.
    CNS drugs, 2020, Volume: 34, Issue:6

    Topics: Analgesics, Opioid; Buprenorphine; Drug Administration Schedule; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Management

2020
Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults.
    Epidemiologic reviews, 2020, 01-31, Volume: 42, Issue:1

    Topics: Adolescent; Buprenorphine; Child; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Young Adult

2020
Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.
    The Medical clinics of North America, 2020, Volume: 104, Issue:4

    Topics: Analgesics, Opioid; Buprenorphine; Harm Reduction; Hospitalization; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Education as Topic

2020
Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
    Drugs, 2020, Volume: 80, Issue:15

    Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Brain; Buprenorphine; Disease Models, Animal; Endocannabinoids; Glutamic Acid; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Orexins; Reward; Secondary Prevention; Signal Transduction; Treatment Outcome

2020
    International journal of disaster risk reduction : IJDRR, 2020, Volume: 49

    Topics: Acyclic Monoterpenes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollutants, Occupational; Amino Acid Transport Systems; Analgesics, Opioid; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Arthrobacter; Bacteria; Bacteriological Techniques; Benzaldehydes; Biodegradation, Environmental; Biofilms; Biological Transport; Biomarkers; Biomass; Bioreactors; Body Composition; Body Mass Index; Brassica; Brazil; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Caco-2 Cells; Cadmium; Calcium; Calcium Carbonate; Calcium Channels; Catalysis; Cell Degranulation; Cell Line; Cell Membrane; Chitosan; Chromatography, High Pressure Liquid; Chromium; Cobalt; Cohort Studies; Colony Count, Microbial; Composting; Copper; COVID-19; Cross-Sectional Studies; Cytoplasm; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diarrhea; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Synergism; Electroplating; Endometrial Neoplasms; Endometrium; Environmental Monitoring; Environmental Restoration and Remediation; Estradiol; Estrogens; Feces; Female; Food Microbiology; Food Preservation; Fruit and Vegetable Juices; Gasotransmitters; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gene Expression Regulation, Developmental; Genetic Predisposition to Disease; Glutathione; Gold; Graphite; Growth Hormone; Harm Reduction; Hot Temperature; Humans; Hydrocortisone; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydrogen-Ion Concentration; Ileum; Imidazoles; Injections, Intraperitoneal; Insecticides; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor I; Intestinal Absorption; Light; Lignin; Liver; Magnetics; Male; Manganese; Mast Cells; Melanoma; Membrane Potentials; Metals; Methadone; Microbial Viability; Microplastics; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Middle Aged; Mitochondrial Swelling; Molecular Dynamics Simulation; Monophenol Monooxygenase; Morocco; Naloxone; Naltrexone; Nanocomposites; Nanomedicine; Nanoparticles; Narcotic Antagonists; Neonicotinoids; Nitric Oxide; Nitro Compounds; Nitrogen; Nitrogen Compounds; Obesity; Obesity, Abdominal; Occupational Exposure; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Oryza; Overweight; Oxidative Stress; Oxides; Oxygen; Perception; Photoelectron Spectroscopy; Plants; Plastics; Point Mutation; Polychlorinated Biphenyls; Polycyclic Aromatic Hydrocarbons; Potassium; Premenopause; Prodrugs; Prospective Studies; Protons; Pyrolysis; Qualitative Research; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resins, Synthetic; Rhodamines; Risk Factors; ROC Curve; Salmo salar; SARS-CoV-2; Seawater; Severity of Illness Index; Sewage; Social Media; Soil; Soil Microbiology; Soil Pollutants; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Staining and Labeling; Stainless Steel; Steel; Stress, Physiological; Substance Abuse Treatment Centers; Symporters; T-Lymphocytes; Toluene; Triclosan; Ultraviolet Rays; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Purification; Welding; X-Ray Diffraction; Young Adult

2020
A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders.
    Drug and alcohol dependence, 2020, 11-01, Volume: 216

    Topics: Analgesics, Opioid; Antidepressive Agents; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Female; Humans; Methadone; Naltrexone; Opioid-Related Disorders

2020
A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.
    Journal of substance abuse treatment, 2020, Volume: 119

    Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2020
Recent Advances in the Treatment of Opioid Use Disorder.
    Current pain and headache reports, 2021, Mar-11, Volume: 25, Issue:4

    Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Drug Implants; Humans; Injections, Intramuscular; Methadone; Molecular Targeted Therapy; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Receptors, G-Protein-Coupled; Receptors, Opioid, mu; Secologanin Tryptamine Alkaloids; Thiophenes; Urea; Vaccines

2021
Pharmacotherapy for Management of 'Kratom Use Disorder': A Systematic Literature Review With Survey of Experts.
    WMJ : official publication of the State Medical Society of Wisconsin, 2021, Volume: 120, Issue:1

    Topics: Buprenorphine; Humans; Methadone; Mitragyna; Naltrexone; Opioid-Related Disorders; United States

2021
Opioid use disorder treatment for people experiencing homelessness: A scoping review.
    Drug and alcohol dependence, 2021, 07-01, Volume: 224

    Topics: Buprenorphine; Health Services Accessibility; Health Services Misuse; Humans; Ill-Housed Persons; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; United States

2021
Effectiveness of medication for opioid use disorders in transition-age youth: A systematic review.
    Journal of substance abuse treatment, 2022, Volume: 132

    Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; United States; Young Adult

2022
Insights into the mechanisms underlying opioid use disorder and potential treatment strategies.
    British journal of pharmacology, 2023, Volume: 180, Issue:7

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders

2023
Diversity inclusion in United States opioid pharmacological treatment trials: A systematic review.
    Experimental and clinical psychopharmacology, 2021, Volume: 29, Issue:5

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; United States

2021
Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018.
    JAMA, 2021, 07-13, Volume: 326, Issue:2

    Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Child; Cross-Sectional Studies; Female; Humans; Male; Medicaid; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; United States; Young Adult

2021
Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review.
    Substance use & misuse, 2021, Volume: 56, Issue:14

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2021
Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race/ethnicity, and gender in the United States.
    Addictive behaviors, 2022, Volume: 124

    Topics: Analgesics, Opioid; Buprenorphine; Ethnicity; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; United States

2022
Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder.
    The Medical clinics of North America, 2022, Volume: 106, Issue:1

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Comorbidity; Disease Management; Drug Overdose; Female; Fentanyl; Harm Reduction; Humans; Male; Mental Disorders; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Practice Guidelines as Topic; Prevalence

2022
Access to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young Adults: A Systematic Review.
    JAMA pediatrics, 2022, Mar-01, Volume: 176, Issue:3

    Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Female; Health Services Accessibility; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Young Adult

2022
An overview of buprenorphine prescribing for the advanced practice psychiatric nurse.
    Perspectives in psychiatric care, 2022, Volume: 58, Issue:4

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2022
Review of medication-assisted treatment for opioid use disorder.
    Journal of osteopathic medicine, 2022, 03-14, Volume: 122, Issue:7

    Topics: Buprenorphine; COVID-19; COVID-19 Drug Treatment; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; United States

2022
Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials.
    PloS one, 2022, Volume: 17, Issue:3

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Morphine; Naltrexone; Network Meta-Analysis; Opioid-Related Disorders; Randomized Controlled Trials as Topic

2022
Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
    Hospital practice (1995), 2022, Volume: 50, Issue:4

    Topics: Analgesics, Opioid; Antiemetics; Benzodiazepines; Buprenorphine; Hospitals; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; United States

2022
Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update.
    Expert opinion on pharmacotherapy, 2022, Volume: 23, Issue:16

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; United States

2022
Opioid Use Disorder Treatments: An Evidence Map.
    Drug and alcohol dependence, 2022, Dec-01, Volume: 241

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2022
Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials.
    Addictive behaviors, 2023, Volume: 139

    Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Craving; Delayed-Action Preparations; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Randomized Controlled Trials as Topic

2023
The Growing Epidemic of Opioid Use Disorder in the Elderly and Its Treatment: A Review of the Literature.
    The primary care companion for CNS disorders, 2023, Jan-10, Volume: 25, Issue:1

    Topics: Aged; Analgesics, Opioid; Buprenorphine; Drug-Related Side Effects and Adverse Reactions; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2023
Treatment of Acute Pain in Patients on Naltrexone: A Narrative Review.
    Current pain and headache reports, 2023, Volume: 27, Issue:7

    Topics: Acute Pain; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain, Postoperative

2023

Trials

47 trial(s) available for methadone and naltrexone

ArticleYear
Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Archives of general psychiatry, 1978, Volume: 35, Issue:3

    Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Heroin; Heroin Dependence; Humans; Male; Methadone; Motivation; Naloxone; Naltrexone; Patient Compliance; Placebos; Research Design; Social Adjustment

1978
Naltrexone in methadone maintenance patients electing to become "drug free".
    NIDA research monograph, 1976, Issue:9

    Topics: Adult; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Patient Dropouts; Research Design

1976
Comments and findings from a naltrexone double blind study.
    NIDA research monograph, 1976, Issue:9

    Topics: Clinical Trials as Topic; Humans; Methadone; Naloxone; Naltrexone; Research Design; Statistics as Topic; Substance-Related Disorders

1976
Clinical experiences with naltrexone in 370 detoxified addicts.
    NIDA research monograph, 1976, Issue:9

    Topics: Clinical Trials as Topic; Cyclazocine; Drug Administration Schedule; Humans; Methadone; Naloxone; Naltrexone; Patient Compliance; Physicians; Placebos; Research Personnel; Substance-Related Disorders

1976
Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.
    NIDA research monograph, 1992, Volume: 121

    Topics: Adult; Blood Pressure; Buprenorphine; Double-Blind Method; Female; Humans; Male; Methadone; Methoxyhydroxyphenylglycol; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1992
Treatment of heroin addicts using buprenorphine.
    The American journal of drug and alcohol abuse, 1991, Volume: 17, Issue:2

    Topics: Adult; Buprenorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Neurologic Examination; Substance Withdrawal Syndrome

1991
Opioid antagonist challenges in buprenorphine maintained patients.
    Drug and alcohol dependence, 1990, Volume: 25, Issue:1

    Topics: Administration, Sublingual; Adult; Buprenorphine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Infusions, Intravenous; Male; Methadone; Naloxone; Naltrexone; Substance Withdrawal Syndrome

1990
Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
    Acta psychiatrica Scandinavica. Supplementum, 1986, Volume: 327

    Topics: Adrenergic Fibers; Animals; Antidepressive Agents, Tricyclic; Brain; Clinical Trials as Topic; Clonidine; Dextropropoxyphene; Drug Therapy, Combination; Heroin Dependence; Humans; Locus Coeruleus; Methadone; Morphine; Naltrexone; Narcotics; Norepinephrine; Rats; Substance Withdrawal Syndrome

1986
Clonidine versus methadone for opiate detoxification.
    Lancet (London, England), 1980, Dec-13, Volume: 2, Issue:8207

    Topics: Clinical Trials as Topic; Clonidine; Humans; Inactivation, Metabolic; Methadone; Naltrexone; Opioid-Related Disorders

1980
The role of narcotic antagonists in the rehabilitation of opiate addicts: a review of naltrexone.
    The American journal of drug and alcohol abuse, 1980, Volume: 7, Issue:1

    Topics: Clinical Trials as Topic; Double-Blind Method; Endorphins; Humans; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Receptors, Opioid

1980
Methadyl acetate (LAAM) in the treatment of heroin addicts. II. Double-blind comparison of gradual and abrupt detoxification.
    Archives of general psychiatry, 1983, Volume: 40, Issue:8

    Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Methadyl Acetate; Naltrexone; Outcome and Process Assessment, Health Care; Placebos; Substance Withdrawal Syndrome

1983
Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.
    Life sciences, 1984, Sep-17, Volume: 35, Issue:12

    Topics: Adult; Blood Pressure; Brain; Female; Humans; Kinetics; Male; Methadone; Methoxyhydroxyphenylglycol; Naloxone; Naltrexone; Narcotics; Norepinephrine; Substance Withdrawal Syndrome; Substance-Related Disorders

1984
Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.
    Archives of general psychiatry, 1982, Volume: 39, Issue:11

    Topics: Adult; Blood Pressure; Clonidine; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Male; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1982
Operant analysis of human heroin self-administration and the effects of naltrexone.
    The Journal of pharmacology and experimental therapeutics, 1981, Volume: 216, Issue:1

    Topics: Adult; Conditioning, Operant; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Placebos; Self Administration

1981
Buprenorphine for benzodiazepine-abusing heroin addicts.
    The American journal of psychiatry, 1994, Volume: 151, Issue:1

    Topics: Administration, Sublingual; Benzodiazepines; Buprenorphine; Heroin Dependence; Humans; Methadone; Naltrexone; Substance-Related Disorders

1994
Assessment of nalmefene glucuronide as a selective gut opioid antagonist.
    Drug and alcohol dependence, 1995, Volume: 39, Issue:2

    Topics: Adult; Arousal; Autonomic Nervous System; Constipation; Dose-Response Relationship, Drug; Gastrointestinal Motility; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Neurologic Examination; Opioid-Related Disorders; Substance Withdrawal Syndrome

1995
Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone.
    The Annals of pharmacotherapy, 1997, Volume: 31, Issue:11

    Topics: Administration, Oral; Adult; Drug Compounding; Drug Stability; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome; Substance-Related Disorders

1997
[Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection].
    Revista clinica espanola, 1997, Volume: 197, Issue:7

    Topics: Adult; Female; Hepatitis C; Humans; Liver; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Necrosis; Prospective Studies; Substance Abuse, Intravenous; Transaminases

1997
Opiate detoxification under anesthesia: no apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure.
    Journal of toxicology. Clinical toxicology, 1999, Volume: 37, Issue:1

    Topics: Acute Kidney Injury; Adult; Anesthesia; Codeine; Female; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Respiratory Insufficiency; Substance Withdrawal Syndrome; Thyroid Hormones

1999
A pilot study of naltrexone-accelerated detoxification in opioid dependence.
    The Medical journal of Australia, 1999, Jul-05, Volume: 171, Issue:1

    Topics: Adolescent; Adult; Analgesics; Anti-Anxiety Agents; Clonidine; Conscious Sedation; Female; Flunitrazepam; Heroin; Heroin Dependence; Hormones; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Octreotide; Pilot Projects; Substance Withdrawal Syndrome; Time Factors

1999
Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.
    JAMA, 2000, Jan-19, Volume: 283, Issue:3

    Topics: Adult; Analgesics, Opioid; Constipation; Double-Blind Method; Female; Gastrointestinal Transit; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Statistics, Nonparametric; Substance Withdrawal Syndrome

2000
Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
    Journal of substance abuse treatment, 2000, Volume: 18, Issue:2

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Anti-Inflammatory Agents, Non-Steroidal; Baclofen; Clonidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; GABA Agents; Heroin Dependence; Humans; Inactivation, Metabolic; Ketoprofen; Male; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Oxazepam; Patient Compliance; Substance Withdrawal Syndrome; Treatment Outcome

2000
Combined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment. A comparative inpatient study.
    Drug and alcohol dependence, 2000, Jun-01, Volume: 59, Issue:3

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Analysis of Variance; Clonidine; Drug Therapy, Combination; Female; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Substance Withdrawal Syndrome; Trazodone

2000
Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
    Drug and alcohol dependence, 2000, May-01, Volume: 59, Issue:2

    Topics: Adult; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Neurologic Examination; Opioid-Related Disorders; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome

2000
Oral methylnaltrexone for opioid-induced constipation.
    JAMA, 2000, Sep-20, Volume: 284, Issue:11

    Topics: Administration, Oral; Adult; Analgesics, Opioid; Constipation; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Quaternary Ammonium Compounds; Single-Blind Method

2000
24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures.
    Addiction biology, 2002, Volume: 7, Issue:2

    Topics: Administration, Oral; Adult; Aftercare; Anti-Anxiety Agents; Benzodiazepines; Clonidine; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Home Care Services, Hospital-Based; Humans; Male; Methadone; Naltrexone; Octreotide; Opioid-Related Disorders; Patient Admission; Substance Withdrawal Syndrome; Time Factors

2002
Interaction between naltrexone and oral THC in heavy marijuana smokers.
    Psychopharmacology, 2003, Volume: 166, Issue:1

    Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Analysis of Variance; Choice Behavior; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Interactions; Female; Heart Rate; Humans; Male; Marijuana Smoking; Methadone; Naltrexone; Narcotic Antagonists; Pain Measurement; Psychomotor Performance; Reaction Time

2003
Use of very low-dose naltrexone during opiate detoxification.
    Journal of addictive diseases, 2003, Volume: 22, Issue:2

    Topics: Adult; Drug Administration Schedule; Female; Humans; Inactivation, Metabolic; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders

2003
Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study.
    European journal of clinical investigation, 2003, Volume: 33, Issue:9

    Topics: Administration, Oral; Administration, Sublingual; Adolescent; Adult; Age Distribution; Buprenorphine; Humans; Male; Methadone; Middle Aged; Naltrexone; Socioeconomic Factors; Substance Abuse, Intravenous; Treatment Outcome

2003
Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence.
    Addiction biology, 2003, Volume: 8, Issue:4

    Topics: Adult; Ambulatory Care; Biological Availability; Combined Modality Therapy; Comorbidity; Delayed-Action Preparations; Drug Administration Schedule; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Mental Disorders; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Dropouts; Premedication; Psychotherapy; Spain; Treatment Outcome

2003
Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD)--correlation with neurophysiological parameters--.
    Neurophysiologie clinique = Clinical neurophysiology, 2004, Volume: 34, Issue:2

    Topics: Acetates; Adult; Amines; Anesthesia; Anesthetics, Intravenous; Cyclohexanecarboxylic Acids; Electric Stimulation; Evoked Potentials, Somatosensory; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Heroin Dependence; Hormone Antagonists; Humans; Magnesium; Male; Median Nerve; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Potassium; Propofol; Restless Legs Syndrome; Somatostatin; Substance Withdrawal Syndrome; Water-Electrolyte Balance

2004
A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
    Biological psychology, 2006, Volume: 71, Issue:3

    Topics: Administration, Oral; Adult; Affect; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Outcome and Process Assessment, Health Care; Personality Inventory; Psychometrics; Secondary Prevention; Substance Withdrawal Syndrome

2006
Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.
    Archives of general psychiatry, 2006, Volume: 63, Issue:2

    Topics: Adolescent; Adult; Cocaine; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Heroin Dependence; Humans; Injections, Subcutaneous; Male; Methadone; Middle Aged; Naltrexone; Narcotics; Placebos; Secondary Prevention; Substance Abuse Detection; Treatment Outcome

2006
Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence.
    Journal of psychiatry & neuroscience : JPN, 2006, Volume: 31, Issue:1

    Topics: Adult; Depression; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists

2006
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial.
    Addiction biology, 2009, Volume: 14, Issue:2

    Topics: Adult; Analgesics, Opioid; Community Mental Health Services; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Inactivation, Metabolic; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Program Development; Substance Withdrawal Syndrome

2009
Naltrexone implants compared to methadone: outcomes six months after prison release.
    European addiction research, 2010, Volume: 16, Issue:3

    Topics: Adult; Crime; Drug Implants; Female; Humans; Male; Methadone; Naltrexone; Opioid-Related Disorders; Prisons; Secondary Prevention

2010
Problem drinking and low-dose naltrexone-assisted opioid detoxification.
    Journal of studies on alcohol and drugs, 2011, Volume: 72, Issue:3

    Topics: Adult; Alcohol Drinking; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult

2011
The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal.
    The American journal of drug and alcohol abuse, 2012, Volume: 38, Issue:3

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Clonidine; Disease Management; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome

2012
Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects.
    Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:3

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Cross-Over Studies; Dietary Sucrose; Double-Blind Method; England; Female; Food Preferences; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Osmolar Concentration; Sodium Chloride, Dietary; Taste Perception; Taste Threshold; Young Adult

2013
Effectiveness of naltrexone in the prevention of delayed respiratory arrest in opioid-naive methadone-intoxicated patients.
    BioMed research international, 2013, Volume: 2013

    Topics: Adolescent; Adult; Analgesics, Opioid; Double-Blind Method; Female; Humans; Iran; Male; Methadone; Naltrexone; Respiration Disorders; Young Adult

2013
Extended-release naltrexone opioid treatment at jail reentry (XOR).
    Contemporary clinical trials, 2016, Volume: 49

    Topics: Analgesics, Opioid; Cause of Death; Delayed-Action Preparations; Drug Overdose; Humans; Injections, Intramuscular; Methadone; Mortality; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Participation; Prisons; Secondary Prevention

2016
The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.
    Contemporary clinical trials, 2016, Volume: 48

    Topics: Analgesics, Opioid; Cooperative Behavior; Criminal Law; Delayed-Action Preparations; Humans; Injections, Intramuscular; Methadone; Naltrexone; Narcotic Antagonists; National Institute on Drug Abuse (U.S.); Opiate Substitution Treatment; Opioid-Related Disorders; Patient Navigation; Prisoners; Prisons; Treatment Outcome; United States

2016
The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
    Trials, 2016, 12-12, Volume: 17, Issue:1

    Topics: Adaptation, Psychological; Analgesics, Opioid; Buprenorphine; Clinical Protocols; Combined Modality Therapy; Drug Users; Health Services Accessibility; Humans; Methadone; Mobile Applications; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Quality of Life; Recurrence; Research Design; Smartphone; Telemedicine; Time Factors; Treatment Outcome; Wisconsin

2016
Pharmacokinetics and pharmacodynamics of a novel analgesic with a deterrent to human opioid abuse (methadone-fluconazole-naltrexone) after oral administration in dogs.
    American journal of veterinary research, 2020, Volume: 81, Issue:8

    Topics: Administration, Oral; Analgesics, Opioid; Animals; Dog Diseases; Dogs; Fluconazole; Methadone; Naltrexone; Opioid-Related Disorders

2020
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial.
    Drug and alcohol dependence, 2021, 02-01, Volume: 219

    Topics: Adult; Animals; Benzazepines; Buprenorphine; Delayed-Action Preparations; Female; Humans; Injections; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Outpatients; Substance Withdrawal Syndrome; Swine

2021
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder.
    Journal of substance abuse treatment, 2022, Volume: 142

    Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Hepatitis C; HIV Infections; Humans; Injections, Intramuscular; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; RNA; Social Justice

2022
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study.
    Contemporary clinical trials, 2023, Volume: 128

    Topics: Buprenorphine; Delayed-Action Preparations; Humans; Injections, Intramuscular; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders

2023

Other Studies

286 other study(ies) available for methadone and naltrexone

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Behavioral effects of narcotic analgesics administered alone or in combination with narcotic antagonists.
    Proceedings of the Western Pharmacology Society, 1976, Volume: 19

    Topics: Analgesics, Opioid; Animals; Avoidance Learning; Behavior, Animal; Drug Interactions; Electroshock; Haplorhini; Macaca fascicularis; Methadone; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Time Factors

1976
Letter: Treatment of accidental naltrexone-induced withdrawal.
    The American journal of psychiatry, 1976, Volume: 133, Issue:2

    Topics: Adult; Humans; Hydromorphone; Male; Methadone; Naloxone; Naltrexone; Substance Withdrawal Syndrome

1976
Conditioned drug responses to naturalistic stimuli.
    NIDA research monograph, 1979, Volume: 27

    Topics: Conditioning, Psychological; Heart Rate; Humans; Hydromorphone; Methadone; Naltrexone; Opioid-Related Disorders; Personality Tests; Self Administration; Skin Temperature

1979
Aversiveness of oral methadone in rats.
    Psychopharmacology, 1978, May-31, Volume: 57, Issue:3

    Topics: Animals; Choice Behavior; Decision Making; Heroin Dependence; Humans; Male; Methadone; Models, Psychological; Naltrexone; Quinine; Rats; Self Administration; Taste; Time Factors

1978
Naltrexone: the clinical investigator's dilemma.
    NIDA research monograph, 1978, Issue:19

    Topics: Adolescent; Adult; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Patient Dropouts; Research Design; Social Adjustment; United States

1978
Clonidine hydrochloride: a nonopiate treatment for opiate withdrawal.
    NIDA research monograph, 1979, Volume: 27

    Topics: Clonidine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1979
The clinical usefulness of narcotic antagonists: implications of behavioral research.
    The American journal of drug and alcohol abuse, 1975, Volume: 2, Issue:3-4

    Topics: Aftercare; Behavior Therapy; Conditioning, Operant; Cyclazocine; Extinction, Psychological; Heroin; Heroin Dependence; Hospitalization; Humans; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Patient Dropouts; Reinforcement, Psychology; Research Design; Self-Assessment

1975
Opioid peptides and opiates differ in receptor selectivity.
    Psychoneuroendocrinology, 1977, Volume: 2, Issue:1

    Topics: Animals; Brain; Dextrorphan; Endorphins; Enkephalins; Isomerism; Levorphanol; Methadone; Morphine; Naloxone; Naltrexone; Rats; Receptors, Opioid

1977
Methadone maintenance and narcotic blocking drugs.
    The International journal of the addictions, 1977, Volume: 12, Issue:7

    Topics: Aftercare; Cyclazocine; Extinction, Psychological; Heroin Dependence; Hospitalization; Humans; Levallorphan; Methadone; Nalorphine; Naloxone; Naltrexone; Narcotic Antagonists; Psychotherapy; Receptors, Opioid

1977
Update of naltrexone treatment.
    NIDA research monograph, 1978, Issue:19

    Topics: Adult; Conditioning, Psychological; Female; Humans; Male; Methadone; Naloxone; Naltrexone; Narcotics; Receptors, Opioid; Social Adjustment; Substance Withdrawal Syndrome; Substance-Related Disorders

1978
Naltrexone in the treatment of opiate dependence.
    NIDA research monograph, 1978, Issue:19

    Topics: Adolescent; Adult; Follow-Up Studies; Forecasting; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Narcotics; New York City; Psychotherapy; Receptors, Opioid; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders

1978
Inhibition by d,l-methadone of RNA and protein synthesis in neonatal mice: antagonism by naloxone or naltrexone.
    European journal of pharmacology, 1978, May-01, Volume: 49, Issue:1

    Topics: Animals; Animals, Newborn; Depression, Chemical; Liver; Methadone; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Protein Biosynthesis; RNA; Time Factors

1978
Midbrain raphe mediation of the narcotic blockade of ovulation.
    Brain research, 1978, Oct-27, Volume: 155, Issue:2

    Topics: Animals; Brain Stem; Female; Luteinizing Hormone; Mesencephalon; Methadone; Morphine; Naltrexone; Ovulation; Raphe Nuclei; Rats

1978
Evaluation of narcotic and narcotic antagonist interactions in primates.
    Annals of the New York Academy of Sciences, 1976, Volume: 281

    Topics: Animals; Cyclazocine; Dextroamphetamine; Diazepam; Drug Interactions; Ethanol; Female; Haplorhini; Humans; Macaca mulatta; Male; Methadone; Methadyl Acetate; Morphine; Morphine Dependence; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Phenytoin; Secobarbital; Self Administration

1976
Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Clinical pharmacology and therapeutics, 1977, Volume: 21, Issue:4

    Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Heroin Dependence; Humans; Male; Methadone; Methods; Naloxone; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders

1977
Naltrexone treatment of opiate-dependent persons.
    Drug and alcohol dependence, 1977, Volume: 2, Issue:3

    Topics: Adult; Humans; Male; Methadone; Middle Aged; Naloxone; Naltrexone; Narcotics; Substance-Related Disorders

1977
Pharmacotherapy of opiate addiction.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1976, May-22, Volume: 50, Issue:22

    Topics: Adolescent; Adult; Cyclazocine; Female; Heroin Dependence; Humans; Male; Methadone; Methadyl Acetate; Naltrexone; Opium; Substance-Related Disorders; United States

1976
Inhibition of nucleic acid synthesis in the regenerating limb of salamanders treated with a DL-methadone or narcotic antagonists.
    Experimental neurology, 1976, Volume: 53, Issue:1

    Topics: Animals; Cyclazocine; Depression, Chemical; DNA; Extremities; Methadone; Naltrexone; Narcotic Antagonists; Regeneration; RNA; Urodela

1976
Long-acting narcotic antagonist complexes.
    National Institute on Drug Abuse research monograph series, 1976, Issue:4

    Topics: Animals; Brain; Diprenorphine; Methadone; Mice; Morphine; Naltrexone; Narcotic Antagonists; Reaction Time; Time Factors

1976
Psychopathology and mood during heroin use: acute vs chronic effects.
    Archives of general psychiatry, 1976, Volume: 33, Issue:12

    Topics: Acute Disease; Adult; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Emotions; Euphoria; Heroin; Heroin Dependence; Humans; Male; Methadone; Morphine; Motor Activity; Naloxone; Naltrexone; Psychopathology

1976
An analysis of naltrexone use--its efficacy, safety and potential.
    NIDA research monograph, 1976, Issue:9

    Topics: Adult; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Methadone; Middle Aged; MMPI; Naloxone; Naltrexone; Outpatient Clinics, Hospital; Patient Compliance; Patient Dropouts; Personality Inventory; Substance-Related Disorders

1976
Interactions of narcotics, narcotic antagonists, and ethanol during acute, chronic, and withdrawal states.
    Annals of the New York Academy of Sciences, 1976, Volume: 281

    Topics: Alcohol Drinking; Animals; Animals, Newborn; Dextrorphan; Drug Interactions; Ethanol; Humans; Levorphanol; Male; Methadone; Methadyl Acetate; Mice; Mice, Inbred C57BL; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors

1976
A unit for delivering multiple drug treatment and prevention services.
    Hospital & community psychiatry, 1975, Volume: 26, Issue:10

    Topics: Adolescent; Adult; Community Mental Health Services; Connecticut; Cyclazocine; Heroin Dependence; Humans; Methadone; Naltrexone; Psychotherapy, Group; Substance-Related Disorders; Vocational Education

1975
On the role of chemotherapy in the treatment of heroin addiction.
    The American journal of drug and alcohol abuse, 1975, Volume: 2, Issue:3-4

    Topics: Heroin Dependence; Humans; Methadone; Methadyl Acetate; Motivation; Naloxone; Naltrexone; Substance-Related Disorders

1975
Clinical experience with naltrexone.
    The American journal of drug and alcohol abuse, 1975, Volume: 2, Issue:3-4

    Topics: Administration, Oral; Adult; Female; Heroin Dependence; Hospitalization; Humans; Male; Methadone; Middle Aged; Morphine; Naloxone; Naltrexone; Outpatient Clinics, Hospital; Patient Dropouts; Placebos; Time Factors

1975
Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program.
    The American journal of drug and alcohol abuse, 1975, Volume: 2, Issue:3-4

    Topics: Adult; Heroin Dependence; Homicide; Humans; Male; Methadone; Methadyl Acetate; Naloxone; Naltrexone; Psychotropic Drugs; Substance-Related Disorders; Suicide

1975
Long-acting narcotic antagonist complexes.
    National Institute on Drug Abuse research monograph series, 1975, Issue:4

    Topics: Aluminum; Animals; Brain; Buffers; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diprenorphine; Drug Stability; Methadone; Mice; Morphine; Naltrexone; Narcotic Antagonists; Reaction Time; Zinc

1975
Heroin addiction. Sequential treatment employing pharmacologic supports.
    Archives of general psychiatry, 1976, Volume: 33, Issue:3

    Topics: Heroin Dependence; Humans; Methadone; Morphine; Naltrexone; Prognosis; Recurrence

1976
Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Behavior, Animal; Benzodiazepines; Benzomorphans; Drug Interactions; Ethylketocyclazocine; Male; Methadone; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Nociceptors; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saimiri; Urination

1992
Nonconventional opioid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells.
    Proceedings of the National Academy of Sciences of the United States of America, 1992, Feb-15, Volume: 89, Issue:4

    Topics: Binding Sites; Calcium; Cell Death; Cell Division; Cell Membrane; Cyclic AMP; Cycloheximide; Dactinomycin; Growth Inhibitors; Humans; Methadone; Morphine; Naltrexone; Nicotine; Pertussis Toxin; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Stereoisomerism; Tumor Cells, Cultured; Virulence Factors, Bordetella

1992
Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation.
    Pharmacology, biochemistry, and behavior, 1992, Volume: 42, Issue:4

    Topics: Adrenal Cortex Hormones; Adrenalectomy; Analgesics; Animals; Brain; Female; Gonadal Steroid Hormones; Male; Methadone; Mice; Morphine; Naltrexone; Narcotics; Orchiectomy; Ovariectomy; Reaction Time; Receptors, Opioid; Sex Characteristics; Up-Regulation

1992
Opioidergic modulation of cocaine conditioned place preferences.
    Life sciences, 1992, Volume: 50, Issue:14

    Topics: Analysis of Variance; Animals; Cocaine; Conditioning, Psychological; Male; Methadone; Naltrexone; Rats; Rats, Inbred Strains; Reference Values; Reinforcement, Psychology

1992
The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine.
    Drug and alcohol dependence, 1991, Volume: 27, Issue:2

    Topics: Animals; Brain; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Methadone; Mice; Mice, Inbred Strains; Morphine; Naltrexone; Receptors, Opioid; Receptors, Opioid, mu; Seizures

1991
Rapid transition from methadone maintenance to naltrexone.
    Lancet (London, England), 1990, Jan-13, Volume: 335, Issue:8681

    Topics: Flumazenil; Humans; Methadone; Midazolam; Naltrexone; Substance Withdrawal Syndrome

1990
Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates.
    The American journal of psychiatry, 1991, Volume: 148, Issue:7

    Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methadone; Midazolam; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1991
Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens.
    European journal of pharmacology, 1990, Apr-10, Volume: 179, Issue:1-2

    Topics: Animals; Cyclazocine; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Ethylketocyclazocine; Guinea Pigs; Ileum; Male; Methadone; Mice; Morphine; Morphine Derivatives; Naltrexone; Receptors, Opioid; Vas Deferens

1990
Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Dose-Response Relationship, Drug; Levallorphan; Male; Methadone; Morphinans; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saimiri

1990
Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:3

    Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Fentanyl; Levorphanol; Male; Methadone; Morphine; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Time Factors

1990
Evidence of single dose opioid dependence in 12- to 14-day-old chicken embryos.
    Pharmacology, biochemistry, and behavior, 1989, Volume: 34, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Chick Embryo; Methadone; Morphine Dependence; Motor Activity; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pyrrolidines; Receptors, Opioid; Substance Withdrawal Syndrome

1989
From theory to practice: the planned treatment of drug users. Interview by Stanley Einstein.
    The International journal of the addictions, 1989, Volume: 24, Issue:7

    Topics: Aftercare; Combined Modality Therapy; Humans; Methadone; Motivation; Naltrexone; Opioid-Related Disorders; Referral and Consultation; Substance-Related Disorders; Therapeutic Community

1989
NIDA's Medication Development Program--1989.
    NIDA research monograph, 1989, Volume: 95

    Topics: Acquired Immunodeficiency Syndrome; Brain; Cocaine; Drug and Narcotic Control; Female; Heroin Dependence; Humans; Infant, Newborn; Methadone; Methadyl Acetate; Naltrexone; Pregnancy; Psychotropic Drugs; Research Support as Topic; Risk Factors; Substance Abuse, Intravenous; Substance-Related Disorders

1989
Naltrexone treatment--the problem of patient acceptance.
    Journal of substance abuse treatment, 1989, Volume: 6, Issue:2

    Topics: Adult; Clonidine; Female; Follow-Up Studies; Humans; Male; Methadone; Naltrexone; Opioid-Related Disorders; Patient Acceptance of Health Care

1989
Endogenous opioids in cerebrospinal fluid of opioid-dependent humans.
    Biological psychiatry, 1988, Volume: 24, Issue:6

    Topics: Adult; beta-Endorphin; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Radioimmunoassay; Radioligand Assay; Receptors, Opioid; Substance Withdrawal Syndrome

1988
Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 244, Issue:3

    Topics: Animals; Benzomorphans; Caudate Nucleus; Dopamine; Male; Methadone; Morphine; Motor Activity; Naloxone; Naltrexone; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reward; Septal Nuclei

1988
Analeptic effect of opiate receptor agonists in rabbits.
    Neuroscience letters, 1985, Mar-22, Volume: 55, Issue:1

    Topics: Animals; Arousal; Brain; Central Nervous System Stimulants; Codeine; Cyclazocine; Dose-Response Relationship, Drug; Enkephalin, Methionine; Ethylketocyclazocine; Etorphine; Male; Meperidine; Methadone; Morphine; Naltrexone; Narcotics; Phenazocine; Rabbits; Receptors, Opioid; Reflex

1985
The role of drugs in the treatment of opioid addicts.
    The Medical journal of Australia, 1986, Oct-20, Volume: 145, Issue:8

    Topics: Alcoholism; Anxiety; Clonidine; Dextropropoxyphene; Heroin; Humans; Inactivation, Metabolic; Kinetics; Methadone; Mood Disorders; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders

1986
Role of opioid antagonists in treating intravenous cocaine abuse.
    Life sciences, 1989, Volume: 44, Issue:13

    Topics: Adult; Buprenorphine; Cocaine; Female; Humans; Injections, Intravenous; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance-Related Disorders

1989
High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications.
    Anesthesiology, 1986, Volume: 64, Issue:5

    Topics: Anesthesia, Spinal; Animals; Blood Pressure; Cats; Drug Tolerance; Fentanyl; Hyperesthesia; Methadone; Morphine; Morphine Derivatives; Naltrexone; Rats; Receptors, Drug; Stimulation, Chemical; Strychnine; Sufentanil; Sulfates; Touch

1986
Opiate addiction and plasma beta-endorphin-like immunoreactivity: methadone maintained, recently detoxified and early naltrexone treated ex-addicts.
    Alcohol and drug research, 1987, Volume: 7, Issue:5-6

    Topics: Adult; beta-Endorphin; Endorphins; Humans; Male; Methadone; Middle Aged; Naltrexone; Opioid-Related Disorders; Time Factors

1987
Naltrexone.
    Journal of substance abuse treatment, 1985, Volume: 2, Issue:2

    Topics: Humans; Methadone; Naltrexone; Opioid-Related Disorders; Pain; Pituitary Gland; Receptors, Opioid; Substance Withdrawal Syndrome

1985
Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Animals; Biological Assay; Buprenorphine; Butorphanol; Cyclazocine; Dose-Response Relationship, Drug; Ethylketocyclazocine; Etorphine; Fentanyl; Methadone; Mice; Morphine; Muscle Contraction; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, mu

1987
CSF endorphins in chronic opioid-dependent humans.
    NIDA research monograph, 1986, Volume: 67

    Topics: Endorphins; Humans; Male; Methadone; Naltrexone; Narcotics; Substance-Related Disorders

1986
Naltrexone: lack of effect on hepatic enzymes.
    Journal of clinical pharmacology, 1988, Volume: 28, Issue:1

    Topics: Adult; Aspartate Aminotransferases; Heroin Dependence; Humans; L-Lactate Dehydrogenase; Liver; Liver Function Tests; Male; Methadone; Naltrexone; Substance-Related Disorders; Time Factors

1988
Primary care of parenteral substance abusers.
    The Nurse practitioner, 1986, Volume: 11, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Administration, Intranasal; Antibodies, Viral; Body Weight; Cocaine; Female; Heart Diseases; Hepatitis; Heroin Dependence; HIV Antibodies; Humans; Injections, Intradermal; Injections, Intravenous; Kidney Diseases; Male; Menstruation Disturbances; Methadone; Naltrexone; Nervous System Diseases; Primary Health Care; Respiratory Tract Diseases; Substance-Related Disorders

1986
The antecedents and benefits of achieving abstinence in opioid addicts: a 2.5-year follow-up study.
    The American journal of drug and alcohol abuse, 1987, Volume: 13, Issue:3

    Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Hospitals, University; Humans; Male; Methadone; Naltrexone; Opioid-Related Disorders; Psychiatric Department, Hospital; Recurrence; Social Adjustment

1987
The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone.
    The American journal of psychiatry, 1986, Volume: 143, Issue:7

    Topics: Adult; Blood Pressure; Clonidine; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Methadone; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders

1986
Psychosocial adjustment, modality choice, and outcome in naltrexone versus methadone treatment.
    The American journal of drug and alcohol abuse, 1986, Volume: 12, Issue:4

    Topics: Adult; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Naltrexone; Opioid-Related Disorders; Social Adjustment

1986
Psychosocial factors in outcome in two opiate addiction treatments.
    Journal of clinical psychology, 1986, Volume: 42, Issue:1

    Topics: Adult; Family; Female; Humans; Life Change Events; Male; Methadone; Middle Aged; Motivation; Naltrexone; Opioid-Related Disorders; Patient Compliance; Psychophysiologic Disorders; Social Support; Somatoform Disorders

1986
Effects of opioids and phencyclidine in combination with naltrexone on the acquisition and performance of response sequences in monkeys.
    Pharmacology, biochemistry, and behavior, 1985, Volume: 22, Issue:6

    Topics: Animals; Cyclazocine; Dose-Response Relationship, Drug; Erythrocebus patas; Female; Heroin; Methadone; Naloxone; Naltrexone; Narcotics; Phencyclidine; Reinforcement Schedule; Serial Learning

1985
Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare.
    Advances in alcohol & substance abuse, 1984,Spring, Volume: 3, Issue:3

    Topics: Adult; Aftercare; Attitude to Health; Clonidine; Female; Follow-Up Studies; Humans; Male; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1984
Anti-endorphin effects of methadone.
    Lancet (London, England), 1980, Nov-01, Volume: 2, Issue:8201

    Topics: Endorphins; Humans; Male; Methadone; Naltrexone; Opioid-Related Disorders; Receptors, Opioid

1980
Clonidine and opiate withdrawal.
    Lancet (London, England), 1980, Nov-15, Volume: 2, Issue:8203

    Topics: Clonidine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1980
The effects of opiate agonists on growth hormone and prolactin release in rats.
    Federation proceedings, 1980, Volume: 39, Issue:8

    Topics: Animals; Apomorphine; Enkephalins; Growth Hormone; Male; Methadone; Morphine; Naloxone; Naltrexone; Parasympathomimetics; Prolactin; Rats; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Opioid; Secretory Rate

1980
Methadone-induced endorphin dysfunction in addicts.
    NIDA research monograph, 1982, Volume: 41

    Topics: Adrenocorticotropic Hormone; Brain; Endorphins; Humans; Hydrocortisone; Male; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Receptors, Opioid; Substance Withdrawal Syndrome

1982
Effect of chronic naltrexone and methadone administration on brain immunoreactive beta-endorphin in the rat.
    Neuroendocrinology, 1983, Volume: 37, Issue:4

    Topics: Animals; beta-Endorphin; Brain Chemistry; Endorphins; Hypothalamus; Male; Methadone; Naloxone; Naltrexone; Radioimmunoassay; Rats; Rats, Inbred Strains

1983
Nonspecific convulsions are induced by morphine but not D-Ala2-methionine-enkephalinamide at cortical sites.
    Brain research, 1984, May-07, Volume: 299, Issue:1

    Topics: Animals; Cerebral Cortex; Drug Tolerance; Electroencephalography; Enkephalin, Methionine; Evoked Potentials; Injections, Intraventricular; Male; Methadone; Morphine; Naltrexone; Rats; Rats, Inbred Strains; Receptors, Opioid; Seizures

1984
Use of naltrexone to extinguish opioid-conditioned responses.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:9 Pt 2

    Topics: Adult; Combined Modality Therapy; Conditioning, Classical; Extinction, Psychological; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Recurrence; Relaxation Therapy

1984
Recent advances in opiate detoxification: clonidine and lofexidine.
    NIDA research monograph, 1983, Volume: 43

    Topics: Clonidine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1983
The index of choice: indications of methadone patients' selection of naltrexone treatment.
    The American journal of drug and alcohol abuse, 1984, Volume: 10, Issue:2

    Topics: Adult; Attitude; Humans; Internal-External Control; Male; Methadone; Motivation; Naloxone; Naltrexone; Opioid-Related Disorders; Patient Acceptance of Health Care; Prospective Studies; Self Concept; Social Environment

1984
Strategies to improve compliance with narcotic antagonists.
    The American journal of drug and alcohol abuse, 1984, Volume: 10, Issue:2

    Topics: Combined Modality Therapy; Humans; Life Style; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Research; Social Support; Substance Withdrawal Syndrome

1984
Methadone and naltrexone in the treatment of heroin dependence.
    The Psychiatric clinics of North America, 1984, Volume: 7, Issue:4

    Topics: Heroin Dependence; Humans; Methadone; Naloxone; Naltrexone; Psychotherapy; Substance Withdrawal Syndrome; Time Factors

1984
Latent inhibition in the aversion to oral methadone.
    Pharmacology, biochemistry, and behavior, 1984, Volume: 20, Issue:3

    Topics: Animals; Avoidance Learning; Extinction, Psychological; Female; Male; Methadone; Naltrexone; Quinine; Rats; Rats, Inbred Strains; Time Factors

1984
Clonidine hydrochloride detoxification from methadone treatments: the value of naltrexone aftercare.
    NIDA research monograph, 1981, Volume: 34

    Topics: Adolescent; Clonidine; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Opium; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors

1981
Effects of selected opioid agonists and antagonists on DMT- and LSD-25-induced disruption of food-rewarded bar pressing behavior in the rat.
    Psychopharmacology, 1981, Volume: 75, Issue:3

    Topics: Animals; Conditioning, Operant; Drug Interactions; Drug Synergism; Lysergic Acid Diethylamide; Male; Methadone; Morphine; N,N-Dimethyltryptamine; Naloxone; Naltrexone; Narcotics; Rats; Reinforcement, Psychology; Tryptamines

1981
Endorphin levels in opioid-dependent human subjects: a longitudinal study.
    Annals of the New York Academy of Sciences, 1982, Volume: 398

    Topics: Adult; Endorphins; Humans; Male; Methadone; Middle Aged; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1982
Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome.
    Archives of general psychiatry, 1982, Volume: 39, Issue:2

    Topics: Adult; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Methadone; Naltrexone; Opioid-Related Disorders; Therapeutic Community

1982
Outpatient opiate detoxification with clonidine.
    The Journal of clinical psychiatry, 1982, Volume: 43, Issue:6 Pt 2

    Topics: Ambulatory Care; Clonidine; Double-Blind Method; Drug Therapy, Combination; Heroin Dependence; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1982
Cardiac and autonomic nervous system effects of L-alphacetylmethadol (LAAM).
    Archives internationales de pharmacodynamie et de therapie, 1982, Volume: 259, Issue:2

    Topics: Animals; Atropine; Autonomic Nervous System; Blood Pressure; Calcium; Drug Interactions; Electric Stimulation; Guinea Pigs; Heart; In Vitro Techniques; Male; Methadone; Methadyl Acetate; Naltrexone; Norepinephrine

1982
Blockade of ovulation by methadone in the rat: a central nervous system-mediated acute effect.
    The Journal of pharmacology and experimental therapeutics, 1980, Volume: 213, Issue:1

    Topics: Animals; Central Nervous System; Electric Stimulation; Female; Luteinizing Hormone; Male; Methadone; Naltrexone; Ovulation; Preoptic Area; Rats

1980
Methadone reduces sexual performances and sexual motivation in the male Syrian golden hamster.
    Pharmacology, biochemistry, and behavior, 1981, Volume: 14, Issue:4

    Topics: Animals; Cricetinae; Dose-Response Relationship, Drug; Male; Mesocricetus; Methadone; Naltrexone; Sexual Behavior, Animal

1981
Clinical pharmacology of mixed agonist-antagonist drugs [proceedings].
    Psychopharmacology bulletin, 1981, Volume: 17, Issue:1

    Topics: Buprenorphine; Cyclazocine; Humans; Methadone; Morphinans; Morphine Dependence; Naltrexone

1981
The clinical use of clonidine in outpatient detoxification from opiates.
    Progress in clinical and biological research, 1981, Volume: 71

    Topics: Clonidine; Dose-Response Relationship, Drug; Heroin Dependence; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Self Administration; Substance Withdrawal Syndrome

1981
[Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
    Annales de medecine interne, 1994, Volume: 145 Suppl 3

    Topics: Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Methadone; Methadyl Acetate; Naltrexone; Narcotics; Patient Compliance; Portugal; Substance-Related Disorders; Time Factors

1994
Role of increase of opioid receptors in granulocyte CD11b/CD18 dysfunction.
    Annals of the New York Academy of Sciences, 1993, Jun-23, Volume: 685

    Topics: Adult; Antigens, CD; CD18 Antigens; Female; Granulocytes; Heroin Dependence; Humans; Macrophage-1 Antigen; Male; Methadone; Naltrexone; Phagocytosis; Receptors, Opioid

1993
A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:2

    Topics: Amino Acid Sequence; Animals; Behavior, Animal; Benzamides; Drug Interactions; Drug Tolerance; Electroshock; Male; Methadone; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Nociceptors; Piperazines; Receptors, Opioid, delta; Receptors, Opioid, mu; Saimiri

1993
Can psychotherapy rescue naltrexone treatment of opioid addiction?
    NIDA research monograph, 1995, Volume: 150

    Topics: Combined Modality Therapy; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Psychotherapy

1995
Effects of chronic treatment with methadone and naltrexone on sleep in addicts.
    European archives of psychiatry and clinical neuroscience, 1996, Volume: 246, Issue:6

    Topics: Adult; Analgesics, Opioid; Female; Heroin; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Sleep; Substance-Related Disorders

1996
The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
    Connecticut medicine, 1996, Volume: 60, Issue:11

    Topics: Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders

1996
Methadone vs naltrexone.
    Connecticut medicine, 1997, Volume: 61, Issue:1

    Topics: Connecticut; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders

1997
Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 282, Issue:2

    Topics: Animals; Buprenorphine; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Methadone; Methadyl Acetate; Morphine; Naltrexone; Narcotic Antagonists; Narcotics

1997
Neonatal withdrawal following pre- and postnatal exposure to methadone in the rat.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:1

    Topics: Animals; Animals, Newborn; Behavior, Animal; Female; Humans; Infant, Newborn; Male; Methadone; Motor Activity; Naltrexone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Pregnancy; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Vocalization, Animal

1998
Apparent thermodynamic parameters of ligand binding to the cloned rat mu-opioid receptor.
    European journal of pharmacology, 1998, Aug-07, Volume: 354, Issue:2-3

    Topics: Analgesics; Animals; Binding, Competitive; CHO Cells; Cricetinae; Diprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Fentanyl; Ligands; Methadone; Morphine; Naltrexone; Narcotic Antagonists; Pentazocine; Peptide Fragments; Peptides; Radioligand Assay; Rats; Receptors, Opioid, mu; Somatostatin; Sufentanil; Thermodynamics; Time Factors

1998
Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage.
    Drug and alcohol dependence, 1998, Oct-01, Volume: 52, Issue:2

    Topics: Adult; Dose-Response Relationship, Drug; Female; Heroin Dependence; Humans; Italy; Male; Methadone; Naltrexone; Patient Dropouts

1998
Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results.
    Drug and alcohol dependence, 1998, Nov-01, Volume: 52, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Anesthesia, General; Clonidine; Drug Therapy, Combination; Feasibility Studies; Female; Follow-Up Studies; Heroin Dependence; Humans; Hypnotics and Sedatives; Length of Stay; Male; Methadone; Midazolam; Naltrexone; Narcotic Antagonists; Neurologic Examination; Ondansetron; Substance Withdrawal Syndrome; Treatment Outcome

1998
The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
    Psychopharmacology, 1998, Volume: 140, Issue:1

    Topics: Animals; Buprenorphine; Butorphanol; Columbidae; Discrimination Learning; Female; Fentanyl; Levallorphan; Methadone; Morphine; Nalbuphine; Nalorphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu

1998
Maintenance programmes are denied to addicted prisoners in Victoria.
    BMJ (Clinical research ed.), 1999, Mar-20, Volume: 318, Issue:7186

    Topics: Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Prisoners; Victoria

1999
Is naltrexone a cure for heroin dependence?
    The Medical journal of Australia, 1999, Jul-05, Volume: 171, Issue:1

    Topics: Australia; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Pilot Projects; Substance Withdrawal Syndrome

1999
Emergency therapeutical approach simulating ultrarapid opioid detoxification in methadone withdrawal precipitated by erroneous administration of naltrexone.
    European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 1999, Volume: 6, Issue:2

    Topics: Adult; Anesthetics, Intravenous; Emergencies; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Propofol; Substance Withdrawal Syndrome

1999
Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.
    Pain, 1999, Volume: 83, Issue:3

    Topics: Adult; Analgesics, Opioid; Constipation; Female; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Pilot Projects; Quaternary Ammonium Compounds

1999
Serendipitous rapid detoxification from opiates: the importance of time-dependent processes.
    Addiction (Abingdon, England), 1999, Volume: 94, Issue:4

    Topics: Adult; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Substance Withdrawal Syndrome; Time Factors

1999
Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
    Psychopharmacology, 2000, Volume: 148, Issue:2

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Dextroamphetamine; Dose-Response Relationship, Drug; Fentanyl; Male; Methadone; Morphine; Nalbuphine; Nalorphine; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu

2000
Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
    Acta anaesthesiologica Scandinavica, 2000, Volume: 44, Issue:3

    Topics: Adult; Anesthesia, General; Codeine; Female; Heroin Dependence; Humans; Male; Methadone; Morphine Dependence; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Prospective Studies; Substance Withdrawal Syndrome

2000
Managing constipation that's opioid-induced.
    RN, 2000, Volume: 63, Issue:6

    Topics: Administration, Oral; Adult; Analgesics, Opioid; Breast Neoplasms; Chemistry, Pharmaceutical; Constipation; Female; Humans; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Quaternary Ammonium Compounds

2000
Morphine discriminative control is mediated by the mu opioid receptor: assessment of delta opioid substitution and antagonism.
    Pharmacology, biochemistry, and behavior, 2000, Volume: 66, Issue:4

    Topics: Animals; Benzamides; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Generalization, Response; Methadone; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Piperazines; Rats; Rats, Long-Evans; Receptors, Opioid, delta; Receptors, Opioid, mu

2000
Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 295, Issue:3

    Topics: Adult; Aged; Brain; Female; Fluorine Radioisotopes; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Naltrexone; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tomography, Emission-Computed

2000
[Evolution and update of detoxification techniques for opiate addicts].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2000, Volume: 20, Issue:4

    Topics: Animals; Buprenorphine; Humans; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome

2000
Methadone enhances human immunodeficiency virus infection of human immune cells.
    The Journal of infectious diseases, 2002, Jan-01, Volume: 185, Issue:1

    Topics: Adult; Drug Interactions; Fetus; HIV Infections; Humans; Immunosuppressive Agents; Macrophages; Methadone; Microglia; Middle Aged; Monocytes; Morphine; Naltrexone; Narcotics; Receptors, CCR5

2002
Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
    Journal of addictive diseases, 2001, Volume: 20, Issue:4

    Topics: Buprenorphine; Electrocardiography; Heroin Dependence; Humans; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Time Factors

2001
[Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
    Lakartidningen, 2002, Jan-17, Volume: 99, Issue:3

    Topics: Controlled Clinical Trials as Topic; Evidence-Based Medicine; Heroin Dependence; Humans; Meta-Analysis as Topic; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Randomized Controlled Trials as Topic; Treatment Outcome

2002
[Documented effect of methadone, but not naltrexone].
    Lakartidningen, 2002, Feb-07, Volume: 99, Issue:6

    Topics: Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Treatment Outcome

2002
[Methadone and naltrexone in heroin addiction--an explanation from the SBU].
    Lakartidningen, 2002, Feb-07, Volume: 99, Issue:6

    Topics: Evidence-Based Medicine; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Social Support; Sweden

2002
Conservative management with naltrexone of an iatrogenic methadone overdose in an opiate-naive patient.
    Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:2

    Topics: Alcoholism; Cocaine-Related Disorders; Diagnosis, Dual (Psychiatry); Drug Overdose; Humans; Male; Medication Errors; Methadone; Middle Aged; Naltrexone; Schizophrenia

2002
Methylnaltrexone reverses opioid-induced constipation.
    The Lancet. Oncology, 2002, Volume: 3, Issue:4

    Topics: Administration, Oral; Analgesics, Opioid; Clinical Trials, Phase II as Topic; Constipation; Humans; Methadone; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds

2002
Dangers involved in rapid opioid detoxification while using opioid antagonists: dehydration and renal failure.
    Addiction (Abingdon, England), 2002, Volume: 97, Issue:8

    Topics: Acute Kidney Injury; Adult; Dehydration; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders

2002
Behavioral naltrexone therapy: an integrated treatment for opiate dependence.
    Journal of substance abuse treatment, 2002, Volume: 23, Issue:4

    Topics: Adult; Behavior Therapy; Combined Modality Therapy; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Patient Compliance; Time Factors; Treatment Outcome

2002
Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 304, Issue:3

    Topics: Acute Disease; Analgesics, Opioid; Animals; Disease Models, Animal; Fentanyl; Male; Methadone; Morphine; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders

2003
Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors.
    The Journal of biological chemistry, 2003, May-23, Volume: 278, Issue:21

    Topics: Animals; Calcium Channel Blockers; Calcium Channels; Electric Conductivity; Endocytosis; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; GTP-Binding Proteins; Methadone; Mice; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Neuroblastoma; Pentazocine; Pituitary Neoplasms; Receptors, Opioid, mu; Transfection; Tumor Cells, Cultured

2003
Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: effect on addictive behaviors and the predictive value of psychiatric comorbidity.
    European addiction research, 2003, Volume: 9, Issue:2

    Topics: Adult; Combined Modality Therapy; Community Mental Health Services; Comorbidity; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Mental Disorders; Methadone; Naltrexone; Narcotic Antagonists; Patient Care Team; Patient Compliance; Patient Dropouts; Psychotherapy; Reinforcement, Psychology; Secondary Prevention

2003
Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:3

    Topics: Animals; Cinnamates; Columbidae; Female; Fentanyl; Methadone; Morphine; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Narcotics; Reaction Time; Receptors, Opioid, mu; Sufentanil

2003
Clinical treatment of opioid addiction and dependence.
    Methods in molecular medicine, 2003, Volume: 84

    Topics: Administration, Oral; Administration, Sublingual; Buprenorphine; Humans; Inactivation, Metabolic; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders

2003
Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone.
    Journal of pain and symptom management, 2003, Volume: 25, Issue:6

    Topics: Administration, Oral; Analgesics, Opioid; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Pain

2003
[Detoxification in withdrawal state in methadone maintenance patients].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2003, Volume: 103, Issue:11

    Topics: Adrenergic alpha-Agonists; Adult; Clonidine; Data Interpretation, Statistical; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Substance Withdrawal Syndrome

2003
Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Addiction (Abingdon, England), 2004, Volume: 99, Issue:4

    Topics: Adult; Analgesics, Opioid; Australia; Buprenorphine; Drug Overdose; Female; Humans; Male; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders

2004
Unexpected delirium during Rapid Opioid Detoxification (ROD).
    Journal of addictive diseases, 2004, Volume: 23, Issue:1

    Topics: Adult; Alcohol Withdrawal Delirium; Clonidine; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Inactivation, Metabolic; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome

2004
Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2004, Volume: 85, Issue:2

    Topics: Australia; Drug Implants; Female; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Pregnancy; Pregnancy Complications; Pregnancy Outcome

2004
Orthoptic status before and immediately after heroin detoxification.
    The British journal of ophthalmology, 2004, Volume: 88, Issue:9

    Topics: Accommodation, Ocular; Adolescent; Adult; Convergence, Ocular; Diplopia; Eye Movements; Heroin; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotics; Refractive Errors; Vision, Binocular; Visual Acuity

2004
Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project.
    Addictive behaviors, 2005, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Ambulatory Care; Analgesics, Opioid; Anesthesia; Buprenorphine; Female; Heroin Dependence; Hospitalization; Humans; Hypnotics and Sedatives; Inactivation, Metabolic; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Treatment Outcome

2005
A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Addictive behaviors, 2006, Volume: 31, Issue:3

    Topics: Adult; Analgesics, Opioid; Analysis of Variance; Buprenorphine; Chi-Square Distribution; Cost-Benefit Analysis; Female; Heroin Dependence; Humans; Hypnotics and Sedatives; Male; Methadone; Naltrexone; Narcotic Antagonists

2006
Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat.
    Psychopharmacology, 2005, Volume: 182, Issue:1

    Topics: Animals; Ethanol; Heroin; Heroin Dependence; Male; Methadone; Microsomes, Liver; Morphine; Morphine Derivatives; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu

2005
Medicalising the treatment of opioid dependence.
    Annals of the Academy of Medicine, Singapore, 2006, Volume: 35, Issue:7

    Topics: Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders

2006
Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:6

    Topics: Adult; Blood Pressure; Cannabinoids; Dronabinol; Female; Hallucinogens; Heart Rate; Humans; Male; Marijuana Smoking; Mental Recall; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Psychomotor Performance; Pupil; Recognition, Psychology; Sex Characteristics; Surveys and Questionnaires

2007
Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    European addiction research, 2007, Volume: 13, Issue:1

    Topics: Adult; Drug Evaluation, Preclinical; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Pilot Projects; Substance Withdrawal Syndrome; Treatment Outcome

2007
Regarding naltrexone for probationers and parolees.
    Journal of substance abuse treatment, 2007, Volume: 32, Issue:2

    Topics: Buprenorphine; Heroin Dependence; Humans; Injections; Long-Term Care; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Pain; Prisoners; Treatment Outcome

2007
Medical treatment of opiate dependence: expanding treatment options.
    The American journal of psychiatry, 2007, Volume: 164, Issue:5

    Topics: Administration, Sublingual; Ambulatory Care; Buprenorphine; Drug Combinations; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Patient Compliance; Randomized Controlled Trials as Topic; Substance Abuse Detection; Treatment Outcome

2007
Does naltrexone affect craving in abstinent opioid-dependent patients?
    Addiction biology, 2007, Volume: 12, Issue:2

    Topics: Adult; Female; Heroin; Heroin Dependence; Humans; Longitudinal Studies; Male; Methadone; Middle Aged; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Secondary Prevention; Substance Abuse Detection; Substance Withdrawal Syndrome; Surveys and Questionnaires

2007
Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records.
    Drug and alcohol review, 2007, Volume: 26, Issue:4

    Topics: Australia; Buprenorphine; Drug Prescriptions; Drug Therapy; Episode of Care; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Registries

2007
Hepatitis C treatment, subcutaneous naltrexone implants, and methadone maintenance treatment.
    Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:3

    Topics: Antiviral Agents; Drug Implants; Hepatitis C; Humans; Methadone; Morphine Dependence; Naltrexone; Narcotics

2007
Pharmacotherapeutic environments for substance use disorders.
    The American journal of drug and alcohol abuse, 2007, Volume: 33, Issue:5

    Topics: Ambulatory Care; Buprenorphine; Cognitive Behavioral Therapy; Delayed-Action Preparations; Family Practice; Heroin Dependence; Hospitalization; Humans; Methadone; Naltrexone; Office Visits; Opioid-Related Disorders; Secondary Prevention; Substance-Related Disorders

2007
Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
    Journal of substance abuse treatment, 2008, Volume: 35, Issue:2

    Topics: Adult; Cohort Studies; Databases, Factual; Drug Implants; Drug Overdose; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Suicide; Time Factors; Western Australia

2008
Behavioral economic analysis of drug preference using multiple choice procedure data.
    Drug and alcohol dependence, 2008, Jan-11, Volume: 93, Issue:1-2

    Topics: Choice Behavior; Economics; Fentanyl; Fluoxetine; Hallucinogens; Humans; Hydromorphone; Injections, Intramuscular; Methadone; Models, Psychological; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotics; Psychotropic Drugs; Recreation; Selective Serotonin Reuptake Inhibitors; Substance Abuse, Intravenous; Substance-Related Disorders

2008
Toward a rational selection of treatment for addiction.
    Current psychiatry reports, 2007, Volume: 9, Issue:6

    Topics: Alleles; Buprenorphine; Genetic Variation; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Substance-Related Disorders

2007
Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Archives of general psychiatry, 2008, Volume: 65, Issue:4

    Topics: Adult; Diagnostic and Statistical Manual of Mental Disorders; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Hospitalization; Humans; Male; Methadone; Morbidity; Naltrexone; Narcotics; Prevalence; Prospective Studies; Retrospective Studies

2008
Community treatment programs take up buprenorphine.
    Science & practice perspectives, 2004, Volume: 2, Issue:2

    Topics: Buprenorphine; Humans; Mental Health Services; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Patient Selection; Substance Abuse Treatment Centers

2004
A 50-year-old woman addicted to heroin: review of treatment of heroin addiction.
    JAMA, 2008, Jul-16, Volume: 300, Issue:3

    Topics: Buprenorphine; Drug Therapy, Combination; Female; Heroin Dependence; History, 19th Century; History, 20th Century; Humans; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Recurrence; Self-Help Groups; United States

2008
Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
    Toxicology and applied pharmacology, 2008, Oct-01, Volume: 232, Issue:1

    Topics: Animals; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Administration Schedule; Hypoglycemic Agents; Immunosuppressive Agents; Injections, Intraperitoneal; Insulin; Methadone; Mice; Naltrexone; Narcotic Antagonists; Pancreas; Receptors, Opioid, mu; Streptozocin; Time Factors

2008
Substitution treatment in Malaysia.
    Lancet (London, England), 2008, Sep-27, Volume: 372, Issue:9644

    Topics: Buprenorphine; Drug Utilization; Heroin Dependence; Humans; Malaysia; Methadone; Naltrexone; Patient Compliance; Pilot Projects; Policy Making

2008
Insufficient information in drug-related hospital morbidity study.
    Archives of general psychiatry, 2009, Volume: 66, Issue:3

    Topics: Hospitals; Humans; Information Dissemination; Medication Errors; Methadone; Naltrexone; Narcotic Antagonists; Substance-Related Disorders

2009
Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle.
    Drug and alcohol dependence, 2009, Aug-01, Volume: 103, Issue:3

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Choice Behavior; Conditioning, Operant; Discrimination, Psychological; Heroin; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Methadone; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Pharmaceutical Vehicles; Rats; Rats, Sprague-Dawley; Stereoisomerism

2009
Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in rats.
    Toxicology letters, 2009, Dec-15, Volume: 191, Issue:2-3

    Topics: Animals; Blood Gas Analysis; Buprenorphine; Catheterization; Fentanyl; Lactic Acid; Male; Methadone; Morphine; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Narcotics; Plethysmography, Whole Body; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Respiratory Insufficiency; Respiratory Mechanics

2009
Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion.
    Anesthesia and analgesia, 2009, Volume: 109, Issue:5

    Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Methadone; Morphine; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Time Factors

2009
First case of stress cardiomyopathy as a result of methadone withdrawal secondary to drug-drug interaction.
    The American journal of emergency medicine, 2010, Volume: 28, Issue:3

    Topics: Adult; Drug Interactions; Echocardiography; Electrocardiography; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Substance Withdrawal Syndrome; Takotsubo Cardiomyopathy

2010
Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
    Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:6

    Topics: Adult; Australia; Diagnosis, Dual (Psychiatry); Drug Implants; Female; Heroin Dependence; Hospitalization; Humans; Longitudinal Studies; Male; Mental Disorders; Methadone; Naltrexone; Opiate Substitution Treatment; Prevalence

2011
The diverse clinical uses of opioid receptor drugs.
    Journal of psychosocial nursing and mental health services, 2010, Volume: 48, Issue:5

    Topics: Analgesics, Opioid; Buprenorphine; Drug Combinations; Humans; Methadone; Naloxone; Naltrexone; Narcotic Antagonists

2010
Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study.
    Substance use & misuse, 2010, Volume: 45, Issue:12

    Topics: Adolescent; Adult; Aged; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Multivariate Analysis; Naltrexone; Narcotic Antagonists; Patient Acceptance of Health Care; Psychotherapy; Social Support; Substance Abuse Treatment Centers; Treatment Outcome

2010
Russian injected drug use soars in face of political inertia.
    Lancet (London, England), 2010, Jul-03, Volume: 376, Issue:9734

    Topics: Drug Implants; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Politics; Russia; Substance Abuse, Intravenous

2010
Addiction treatment in Russia.
    Lancet (London, England), 2010, Oct-02, Volume: 376, Issue:9747

    Topics: Behavior, Addictive; Buprenorphine; Delayed-Action Preparations; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Recurrence; Russia; Substance Abuse, Intravenous; Suicide Prevention

2010
Heteromerization of the μ- and δ-opioid receptors produces ligand-biased antagonism and alters μ-receptor trafficking.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:3

    Topics: Animals; Calcium; Endocytosis; HEK293 Cells; Humans; Ligands; Methadone; Mice; Naltrexone; Protein Transport; Receptors, Opioid, delta; Receptors, Opioid, mu; Signal Transduction

2011
THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.
    Behavioural pharmacology, 2011, Volume: 22, Issue:5-6

    Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Locomotion; Male; Methadone; Naltrexone; Narcotic Antagonists; Pain; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu

2011
Characterization of the antinociceptive effects of the individual isomers of methadone after acute and chronic administrations.
    Behavioural pharmacology, 2011, Volume: 22, Issue:5-6

    Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Male; Methadone; Naltrexone; Narcotic Antagonists; Pain; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, mu; Stereoisomerism

2011
Promise of extended-release naltrexone is a red herring.
    Lancet (London, England), 2011, Aug-20, Volume: 378, Issue:9792

    Topics: Buprenorphine; Delayed-Action Preparations; Humans; Injections; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Russia

2011
Injectable extended-release naltrexone for opioid dependence.
    Lancet (London, England), 2011, Aug-20, Volume: 378, Issue:9792

    Topics: Administration, Oral; Delayed-Action Preparations; Drug Implants; Humans; Injections; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Russia

2011
Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
    Substance abuse, 2012, Volume: 33, Issue:1

    Topics: Adult; Buprenorphine; Crime; Criminal Law; Data Collection; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Prisons; Substance-Related Disorders; Young Adult

2012
[Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification].
    Vojnosanitetski pregled, 2012, Volume: 69, Issue:4

    Topics: Adult; Depression; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Young Adult

2012
Clinically employed opioid analgesics produce antinociception via μ-δ opioid receptor heteromers in Rhesus monkeys.
    ACS chemical neuroscience, 2012, Sep-19, Volume: 3, Issue:9

    Topics: Analgesics; Analgesics, Opioid; Animals; Calcium Signaling; Data Interpretation, Statistical; Female; Fentanyl; HEK293 Cells; Humans; Injections, Spinal; Macaca mulatta; Male; Methadone; Mice; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Receptors, Opioid, mu

2012
Opioid dependence.
    American family physician, 2012, Sep-15, Volume: 86, Issue:6

    Topics: Buprenorphine; Clonidine; Evidence-Based Medicine; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prognosis; Risk Factors; Substance Withdrawal Syndrome; Time Factors

2012
Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
    Addiction (Abingdon, England), 2013, Volume: 108, Issue:2

    Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Risk Assessment; Treatment Outcome

2013
Blocking endogenous opioids during development--do we understand the consequences?
    Addiction (Abingdon, England), 2013, Volume: 108, Issue:2

    Topics: Animals; Brain; Buprenorphine; Female; Fetal Development; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome

2013
Impact of opioid pharmacotherapy on arterial stiffness and vascular ageing: cross-sectional and longitudinal studies.
    Cardiovascular toxicology, 2013, Volume: 13, Issue:3

    Topics: Adult; Aging; Blood Vessels; Buprenorphine; Cross-Sectional Studies; Endothelium, Vascular; Female; Heroin Dependence; Humans; Longitudinal Studies; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Phenotype; Pulse Wave Analysis; Regression Analysis; Vascular Stiffness

2013
Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Mar-06, Volume: 33, Issue:10

    Topics: Analgesics, Opioid; Animals; Brain; Diprenorphine; Dose-Response Relationship, Drug; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Excitatory Amino Acid Antagonists; Female; GABA Antagonists; gamma-Aminobutyric Acid; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine 5'-O-(3-Thiotriphosphate); Hot Temperature; Humans; Hyperalgesia; Inhibitory Postsynaptic Potentials; Isotopes; Male; Methadone; Mice; Mice, Transgenic; Morphine; Mutation; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Oligopeptides; Pain Measurement; Patch-Clamp Techniques; Pertussis Toxin; Protein Binding; Reaction Time; RGS Proteins; Signal Transduction; Spinal Cord

2013
'Miracle cure' or 'liquid handcuffs': reporting on naltrexone and methadone in the Australian print media.
    Drug and alcohol review, 2014, Volume: 33, Issue:5

    Topics: Australia; Heroin Dependence; Humans; Mass Media; Methadone; Naltrexone; Newspapers as Topic; Opiate Substitution Treatment; Public Opinion; Treatment Outcome

2014
Comment on "Effectiveness of naltrexone in the prevention of delayed respiratory arrest in opioid-naive methadone-intoxicated patients".
    BioMed research international, 2014, Volume: 2014

    Topics: Analgesics, Opioid; Female; Humans; Male; Methadone; Naltrexone; Respiration Disorders

2014
Informed consent abandoned--patient given contraindicated drug.
    Journal of the Medical Association of Georgia, 2014, Volume: 103, Issue:2

    Topics: Alcoholism; Contraindications; Depressive Disorder; Humans; Informed Consent; Male; Medication Reconciliation; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Pain; Risk Management; Treatment Outcome

2014
The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol.
    Systematic reviews, 2014, Sep-19, Volume: 3

    Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Heroin; Humans; Methadone; Naloxone; Naltrexone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Research Design; Systematic Reviews as Topic

2014
Excess mortality among opioid-using patients treated with oral naltrexone in Australia.
    Drug and alcohol review, 2015, Volume: 34, Issue:1

    Topics: Administration, Oral; Australia; Cohort Studies; Humans; Methadone; Naltrexone; Narcotic Antagonists; New South Wales; Opiate Substitution Treatment; Opioid-Related Disorders; Washington

2015
Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence.
    Substance abuse, 2015, Volume: 36, Issue:2

    Topics: Adolescent; Adult; Aged; Buprenorphine; Computer Simulation; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Humans; Injections; Male; Markov Chains; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Young Adult

2015
Comment on "Effectiveness of naltrexone in the prevention of delayed respiratory arrest in opioid-naive methadone-intoxicated patients".
    BioMed research international, 2015, Volume: 2015

    Topics: Analgesics, Opioid; Female; Humans; Male; Methadone; Naltrexone; Respiration Disorders

2015
Medicaid coverage of medications to treat alcohol and opioid dependence.
    Journal of substance abuse treatment, 2015, Volume: 55

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Buprenorphine, Naloxone Drug Combination; Humans; Insurance Coverage; Medicaid; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Taurine; United States

2015
Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.
    The Journal of clinical investigation, 2015, Jul-01, Volume: 125, Issue:7

    Topics: Alternative Splicing; Analgesics, Opioid; Animals; Exons; Gene Targeting; Methadone; Mice; Mice, Knockout; Morphine; Naltrexone; Pain; Peptide Fragments; Protein Structure, Tertiary; Receptors, Opioid, mu; Recombinant Proteins

2015
Severe opioid withdrawal syndrome after a single dose of nalmefene.
    European journal of clinical pharmacology, 2015, Volume: 71, Issue:8

    Topics: Adult; Alcoholism; Analgesics, Opioid; Codeine; Contraindications; Drug Interactions; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome

2015
Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World.
    Journal of addictive diseases, 2015, Volume: 34, Issue:2-3

    Topics: Behavior, Addictive; Buprenorphine; Global Health; Health Services Accessibility; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prescription Drug Misuse; United States

2015
[Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions].
    Praxis, 2015, Oct-14, Volume: 104, Issue:21

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Alcoholism; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Pharmacovigilance; Substance Withdrawal Syndrome

2015
Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients.
    Drug and alcohol dependence, 2016, Mar-01, Volume: 160

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Logistic Models; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Retrospective Studies; Social Justice; United States; United States Department of Veterans Affairs; Veterans

2016
Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.
    Journal of substance abuse treatment, 2016, Volume: 66

    Topics: Adult; Buprenorphine; Delayed-Action Preparations; Female; Humans; Interviews as Topic; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference; Substance Withdrawal Syndrome; Young Adult

2016
A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Drugs, 2017, Volume: 77, Issue:11

    Topics: Adult; Australia; Buprenorphine; Drug Administration Routes; Female; Humans; Incidence; Infant, Newborn; Male; Methadone; Naltrexone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Retrospective Studies

2017
Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.
    The International journal on drug policy, 2017, Volume: 46

    Topics: Adult; Buprenorphine; Cohort Studies; Drug Implants; Drug Overdose; Female; Humans; Male; Methadone; Multivariate Analysis; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Prospective Studies; Retrospective Studies; Risk Factors; Western Australia; Young Adult

2017
A retrospective cohort study of the health of children prenatally exposed to methadone, buprenorphine or naltrexone compared with non-exposed control children.
    The American journal on addictions, 2017, Volume: 26, Issue:8

    Topics: Adult; Buprenorphine; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Longitudinal Studies; Male; Methadone; Naltrexone; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Western Australia

2017
Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions.
    The American journal of drug and alcohol abuse, 2018, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Young Adult

2018
Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration.
    Drug and alcohol dependence, 2018, 02-01, Volume: 183

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Comorbidity; Cross-Sectional Studies; Female; Humans; Injections, Intramuscular; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Treatment Outcome; United States; United States Department of Veterans Affairs; Veterans; Veterans Health

2018
Healthcare utilization and costs associated with treatment for opioid dependence.
    Journal of medical economics, 2018, Volume: 21, Issue:4

    Topics: Adult; Age Factors; Buprenorphine; Comorbidity; Counseling; Delayed-Action Preparations; Health Expenditures; Health Resources; Humans; Male; Methadone; Middle Aged; Models, Econometric; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies

2018
Time-dependent regional brain distribution of methadone and naltrexone in the treatment of opioid addiction.
    Addiction biology, 2019, Volume: 24, Issue:3

    Topics: Animals; Brain; Caudate Nucleus; Cerebral Cortex; Hippocampus; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Putamen; Rats, Sprague-Dawley

2019
Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.
    JAMA psychiatry, 2018, 04-01, Volume: 75, Issue:4

    Topics: Adolescent; Adult; Buprenorphine; Cause of Death; Drug Overdose; Female; Fentanyl; Health Plan Implementation; Humans; Male; Methadone; Middle Aged; Naltrexone; Odds Ratio; Opioid-Related Disorders; Patient Discharge; Prisoners; Prisons; Retrospective Studies; Rhode Island; Transitional Care; Young Adult

2018
Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury.
    JAMA psychiatry, 2018, 06-01, Volume: 75, Issue:6

    Topics: Analgesics, Opioid; Brain Injuries, Traumatic; Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Pain; Receptors, Opioid, mu

2018
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
    Annals of internal medicine, 2018, 08-07, Volume: 169, Issue:3

    Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Drug Overdose; Female; Humans; Male; Massachusetts; Methadone; Middle Aged; Mortality; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Retrospective Studies; Young Adult

2018
Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.
    The New England journal of medicine, 2018, Jul-05, Volume: 379, Issue:1

    Topics: Buprenorphine; Drug Approval; Drug Overdose; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Primary Health Care; United States; United States Food and Drug Administration

2018
Methylnaltrexone-Associated Bowel Perforation in Postoperative Opioid-Induced Constipation and Ogilvie Syndrome: A Case Report.
    A&A practice, 2019, Jan-15, Volume: 12, Issue:2

    Topics: Analgesics, Opioid; Colonic Pseudo-Obstruction; Constipation; Decompression, Surgical; Humans; Hydromorphone; Intestinal Perforation; Low Back Pain; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Postoperative Complications; Quaternary Ammonium Compounds; Spinal Stenosis

2019
High drug related mortality rates following prison release: Assessing the acceptance likelihood of a naltrexone injection and related concerns.
    Journal of substance abuse treatment, 2018, Volume: 92

    Topics: Adult; Dose-Response Relationship, Drug; England; Heroin Dependence; Humans; Injections; Likelihood Functions; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Acceptance of Health Care; Prisoners; Young Adult

2018
Overview of Drugs Used to Treat Opioid Use Disorder.
    The American journal of nursing, 2018, Volume: 118, Issue:8

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Nurse's Role; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Education as Topic

2018
Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime.
    The American journal of psychiatry, 2018, 10-01, Volume: 175, Issue:10

    Topics: Acamprosate; Adult; Aged; Alcohol Deterrents; Alcoholism; Buprenorphine; Cohort Studies; Crime; Drug Overdose; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors; Suicidal Ideation; Young Adult

2018
Telemedicine's Role in Addressing the Opioid Epidemic.
    Mayo Clinic proceedings, 2018, Volume: 93, Issue:9

    Topics: Analgesics, Opioid; Buprenorphine; Epidemics; Health Policy; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Telemedicine; United States

2018
[Illogical association nalmefene and opioids: Analysis in the French pharmacovigilance database].
    Therapie, 2019, Volume: 74, Issue:3

    Topics: Analgesics, Opioid; Databases, Factual; Drug Labeling; France; Humans; Methadone; Naltrexone; Narcotic Antagonists; Pharmacovigilance

2019
The First Comprehensive Program for Opioid Use Disorder in a US Statewide Correctional System.
    American journal of public health, 2018, Volume: 108, Issue:10

    Topics: Buprenorphine; Female; Humans; Male; Mass Screening; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Rhode Island; United States

2018
Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder.
    JAMA pediatrics, 2018, 11-01, Volume: 172, Issue:11

    Topics: Adolescent; Behavior Therapy; Buprenorphine; Female; Humans; Male; Methadone; Naltrexone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Retention in Care; Retrospective Studies; Time Factors; United States; Young Adult

2018
Involvement of central opioid receptors in protective effects of methadone on experimental colitis in rats.
    Inflammopharmacology, 2018, Volume: 26, Issue:6

    Topics: Acetic Acid; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Injections, Intraventricular; Injections, Subcutaneous; Interleukin-1beta; Intestinal Mucosa; Male; Methadone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid; Tumor Necrosis Factor-alpha

2018
Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science.
    Journal of substance abuse treatment, 2018, Volume: 95

    Topics: Buprenorphine; Hospitals, Veterans; Humans; Implementation Science; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Quality Improvement; Quality Indicators, Health Care; United States; United States Department of Veterans Affairs; Veterans

2018
Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs.
    Journal of studies on alcohol and drugs, 2018, Volume: 79, Issue:6

    Topics: Analgesics, Opioid; Buprenorphine; Cohort Studies; Female; Hospitals, Veterans; Humans; Male; Methadone; Naltrexone; Opioid-Related Disorders; Residential Treatment; United States; United States Department of Veterans Affairs; Veterans

2018
Medication-assisted treatment for opioid use disorder.
    The Nurse practitioner, 2019, Volume: 44, Issue:3

    Topics: Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Nurse Practitioners; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Nurses'; United States

2019
Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?
    Addiction (Abingdon, England), 2019, Volume: 114, Issue:8

    Topics: Analgesics, Opioid; Buprenorphine; Diagnostic and Statistical Manual of Mental Disorders; Evidence-Based Medicine; Humans; International Classification of Diseases; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Reported Outcome Measures; Remission Induction

2019
Suppression of Human Natural Killer Cells by Different Classes of Opioids.
    Anesthesia and analgesia, 2019, Volume: 128, Issue:5

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Anesthesia; Buprenorphine; Enkephalin, D-Penicillamine (2,5)-; Fentanyl; Fluoresceins; Humans; Immunosuppression Therapy; K562 Cells; Killer Cells, Natural; Loperamide; Methadone; Morphinans; Morphine; Naloxone; Naltrexone; Succinimides; Toll-Like Receptor 4; Tramadol

2019
Prescription Drug and Alcohol Use Disorders: Opioid Use Disorder.
    FP essentials, 2019, Volume: 478

    Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy

2019
A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphine.
    The American journal of drug and alcohol abuse, 2019, Volume: 45, Issue:3

    Topics: Buprenorphine; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Retrospective Studies

2019
Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.
    Substance abuse, 2019, Volume: 40, Issue:2

    Topics: Adult; Antidiarrheals; Antiemetics; Antipruritics; Buprenorphine; Clonidine; Deprescriptions; Drug Substitution; Female; Humans; Loperamide; Methadone; Methocarbamol; Muscle Relaxants, Central; Naltrexone; Narcotic Antagonists; Ondansetron; Opiate Substitution Treatment; Opioid-Related Disorders; Promethazine; Substance Withdrawal Syndrome; Sympatholytics

2019
Concurrent Use of Buprenorphine, Methadone, or Naltrexone Does Not Inhibit Ketamine's Antidepressant Activity.
    Biological psychiatry, 2019, 06-15, Volume: 85, Issue:12

    Topics: Adult; Aged; Analgesics, Opioid; Antidepressive Agents; Buprenorphine; Depressive Disorder, Treatment-Resistant; Female; Humans; Ketamine; Male; Methadone; Middle Aged; Naltrexone; Treatment Outcome

2019
News Media Reporting On Medication Treatment For Opioid Use Disorder Amid The Opioid Epidemic.
    Health affairs (Project Hope), 2019, Volume: 38, Issue:4

    Topics: Analgesics, Opioid; Buprenorphine; Female; Health Education; Health Information Management; Humans; Information Dissemination; Male; Mass Media; Medical Informatics; Methadone; Naltrexone; Needs Assessment; Opiate Substitution Treatment; Opioid Epidemic; Opioid-Related Disorders; Public Health; Retrospective Studies; Risk Assessment; United States

2019
Methadone's effects on pentylenetetrazole-induced seizure threshold in mice: NMDA/opioid receptors and nitric oxide signaling.
    Annals of the New York Academy of Sciences, 2019, Volume: 1449, Issue:1

    Topics: Animals; Anticonvulsants; Dizocilpine Maleate; Guanidines; Indazoles; Ketamine; Male; Methadone; Mice; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pentylenetetrazole; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Seizures

2019
Medication-Based Treatment to Address Opioid Use Disorder.
    JAMA, 2019, Jun-04, Volume: 321, Issue:21

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Stereotyping

2019
The case for a medication first approach to the treatment of opioid use disorder.
    The American journal of drug and alcohol abuse, 2019, Volume: 45, Issue:4

    Topics: Analgesics, Opioid; Buprenorphine; Certification; Health Plan Implementation; Health Services Accessibility; Humans; Methadone; Missouri; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; State Government

2019
Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
    Substance abuse treatment, prevention, and policy, 2019, 06-25, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Age Factors; Buprenorphine; Drug Utilization; Female; Humans; Male; Medicaid; Methadone; Middle Aged; Naltrexone; New York; Opiate Substitution Treatment; Opioid-Related Disorders; United States; Young Adult

2019
Use of naltrexone in treating opioid use disorder in pregnancy.
    American journal of obstetrics and gynecology, 2020, Volume: 222, Issue:1

    Topics: Abortion, Spontaneous; Adult; Analgesics, Opioid; Buprenorphine; Case-Control Studies; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prospective Studies; Stillbirth; Young Adult

2020
US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016.
    Journal of general internal medicine, 2020, Volume: 35, Issue:3

    Topics: Buprenorphine; Drug Overdose; Emergency Service, Hospital; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; Retrospective Studies; United States

2020
Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Substance use & misuse, 2019, Volume: 54, Issue:14

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Health Services Accessibility; Humans; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care; Young Adult

2019
Optimising opioid substitution therapy in the prison environment.
    International journal of prisoner health, 2019, 12-05, Volume: 15, Issue:4

    Topics: Age Factors; Buprenorphine; Comorbidity; Continuity of Patient Care; Delayed-Action Preparations; Drug Administration Schedule; England; Hepatitis C; HIV Infections; Humans; Mental Disorders; Methadone; Naltrexone; Narcotics; Needle Sharing; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Quality Improvement; Social Work; Wales

2019
Attitudes toward opioid use disorder medications: Results from a U.S. national study of individuals who resolved a substance use problem.
    Experimental and clinical psychopharmacology, 2020, Volume: 28, Issue:4

    Topics: Adolescent; Adult; Attitude; Buprenorphine, Naloxone Drug Combination; Female; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; United States; Young Adult

2020
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Addiction science & clinical practice, 2019, 10-01, Volume: 14, Issue:1

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Continuity of Patient Care; Delayed-Action Preparations; Female; Health Services Accessibility; Humans; Interviews as Topic; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Satisfaction; Prisoners; Qualitative Research; Socioeconomic Factors

2019
Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.
    Annals of emergency medicine, 2020, Volume: 75, Issue:1

    Topics: Adolescent; Adult; Age Distribution; Analgesics, Opioid; Buprenorphine; Databases, Factual; Drug Overdose; Female; Humans; Male; Massachusetts; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Retrospective Studies; Time-to-Treatment; Young Adult

2020
Characteristics and current clinical practices of opioid treatment programs in the United States.
    Drug and alcohol dependence, 2019, 12-01, Volume: 205

    Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Mass Screening; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Abuse Treatment Centers; Surveys and Questionnaires; Telemedicine; United States

2019
Medications for opioid use disorders: clinical and pharmacological considerations.
    The Journal of clinical investigation, 2020, 01-02, Volume: 130, Issue:1

    Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders

2020
An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
    Substance abuse, 2020, Volume: 41, Issue:2

    Topics: Analgesics, Opioid; Beneficence; Buprenorphine; Correctional Facilities; Evidence-Based Practice; Health Services Accessibility; Humans; Mental Health Services; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Personal Autonomy; Prisoners; Public Health; Social Justice

2020
Help Is on the Way: Medicare Coverage of Opioid Treatment Programs.
    Journal of the American Geriatrics Society, 2020, Volume: 68, Issue:3

    Topics: Aged; Analgesics, Opioid; Buprenorphine; Humans; Medicare; Methadone; Naltrexone; Opioid-Related Disorders; United States

2020
Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis.
    The American journal on addictions, 2020, Volume: 29, Issue:2

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Endocarditis; Female; Humans; Injections; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Odds Ratio; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Patient Discharge; Retrospective Studies; Treatment Refusal

2020
Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
    JAMA network open, 2020, 02-05, Volume: 3, Issue:2

    Topics: Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Health Services Accessibility; Humans; Medicaid; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Residential Treatment; Substance Abuse Treatment Centers; United States

2020
Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
    Addiction (Abingdon, England), 2020, Volume: 115, Issue:9

    Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Cause of Death; Cohort Studies; Drug Overdose; Female; Humans; Male; Maryland; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Retrospective Studies; Time Factors; United States; Young Adult

2020
Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.
    Addiction (Abingdon, England), 2020, Volume: 115, Issue:8

    Topics: Adolescent; Adult; Buprenorphine; Cohort Studies; Drug Overdose; Female; Humans; Male; Massachusetts; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Residential Treatment; Retrospective Studies; Substance Withdrawal Syndrome; Young Adult

2020
Diagnosis and Treatment of Opioid Use Disorder in 2020.
    JAMA, 2020, 05-26, Volume: 323, Issue:20

    Topics: Adult; Buprenorphine; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Drug and Narcotic Control; Harm Reduction; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Psychotherapy; Sensitivity and Specificity

2020
Receipt of training about medication for opioid use disorder from pharmaceutical manufacturers: A preliminary study of Florida criminal problem-solving and dependency court staff.
    Drug and alcohol review, 2020, Volume: 39, Issue:5

    Topics: Analgesics, Opioid; Buprenorphine; Criminals; Cross-Sectional Studies; Drug Industry; Florida; Humans; Judicial Role; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Problem Solving

2020
Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
    Substance abuse, 2020, Volume: 41, Issue:3

    Topics: Ambulatory Care Facilities; Analgesics, Opioid; Buprenorphine; Delivery of Health Care; Health Services Accessibility; Hospitals, Veterans; Humans; Implementation Science; Mental Health Services; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Clinics; Primary Health Care; Teacher Training; United States; United States Department of Veterans Affairs; Veterans Health Services

2020
Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians.
    Drug and alcohol dependence, 2020, 11-01, Volume: 216

    Topics: Buprenorphine; Drug Prescriptions; Female; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Physicians, Primary Care; Primary Health Care; Surveys and Questionnaires; United States

2020
Relative Cost Differences of Initial Treatment Strategies for Newly Diagnosed Opioid Use Disorder: A Cohort Study.
    Medical care, 2020, Volume: 58, Issue:10

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Behavior Therapy; Buprenorphine; Cohort Studies; Female; Health Care Costs; Hospitalization; Humans; Male; Medicare; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; United States

2020
A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
    Substance abuse treatment, prevention, and policy, 2020, 09-14, Volume: 15, Issue:1

    Topics: Analgesics, Opioid; Attitude of Health Personnel; Buprenorphine; Delayed-Action Preparations; Drug and Narcotic Control; Female; Humans; Insurance Coverage; Insurance, Health; Male; Mental Disorders; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; Specialization; United States

2020
Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.
    The American journal of drug and alcohol abuse, 2020, 11-01, Volume: 46, Issue:6

    Topics: Analgesics, Opioid; Buprenorphine; Case Managers; Counselors; Criminal Law; Criminals; Cross-Sectional Studies; Female; Florida; Health Knowledge, Attitudes, Practice; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2020
Perioperative analgesia associated with oral administration of a novel methadone-fluconazole-naltrexone formulation in dogs undergoing routine ovariohysterectomy.
    American journal of veterinary research, 2020, Volume: 81, Issue:9

    Topics: Administration, Oral; Analgesia; Analgesics, Opioid; Animals; Dog Diseases; Dogs; Female; Fluconazole; Humans; Hysterectomy; Methadone; Naltrexone; Ovariectomy; Pain, Postoperative

2020
Implementation of a Medication for Addiction Treatment (MAT) and Linkage Program by Leveraging Community Partnerships and Medical Toxicology Expertise.
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2021, Volume: 17, Issue:2

    Topics: Adult; Buprenorphine; Female; Humans; Interprofessional Relations; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Care Team; United States

2021
Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.
    PloS one, 2020, Volume: 15, Issue:11

    Topics: Buprenorphine; Electrocardiography; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Induced Pluripotent Stem Cells; Ion Channel Gating; Methadone; Myocytes, Cardiac; Naloxone; Naltrexone; Potassium Channel Blockers; Receptors, Opioid; Time Factors

2020
COVID-19 and treating incarcerated populations for opioid use disorder.
    Journal of substance abuse treatment, 2021, Volume: 124

    Topics: Buprenorphine; COVID-19; Humans; Massachusetts; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners; Prisons; Public Health; Telemedicine

2021
A study of the effectiveness of naltrexone in preventing recurrence of methadone poisoning in opioid-naive children.
    Drug and alcohol dependence, 2021, 02-01, Volume: 219

    Topics: Adolescent; Aftercare; Analgesics, Opioid; Child; Child, Preschool; Female; Hospitalization; Humans; Infant; Intensive Care Units; Iran; Male; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Neoplasms; Patient Discharge; Poisoning; Recurrence; Retrospective Studies

2021
The relationship between dissociative symptoms and the medications used in the treatment of opioid use disorder.
    Journal of substance abuse treatment, 2021, Volume: 121

    Topics: Buprenorphine; Female; Humans; Male; Methadone; Naltrexone; Ohio; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Health Questionnaire

2021
An anesthesiologist-led inpatient buprenorphine initiative.
    Pain practice : the official journal of World Institute of Pain, 2021, Volume: 21, Issue:6

    Topics: Analgesics, Opioid; Anesthesiologists; Buprenorphine; Humans; Inpatients; Methadone; Naltrexone; Opioid-Related Disorders

2021
Medication for Adolescents and Young Adults With Opioid Use Disorder.
    The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2021, Volume: 68, Issue:3

    Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Young Adult

2021
Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.
    JAMA network open, 2021, 02-01, Volume: 4, Issue:2

    Topics: Accidental Falls; Adult; Alcohol-Related Disorders; Alcoholism; Analgesics, Opioid; Buprenorphine; Central Nervous System Depressants; Drug Overdose; Ethanol; Female; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Protective Factors; Wounds and Injuries; Young Adult

2021
Multiple-dose pharmacokinetics and opioid effects of a novel analgesic with a deterrent to human opioid abuse (methadone-fluconazole-naltrexone) after oral administration in dogs.
    American journal of veterinary research, 2021, Volume: 82, Issue:3

    Topics: Administration, Oral; Analgesics; Analgesics, Opioid; Animals; Dog Diseases; Dogs; Fluconazole; Humans; Methadone; Naltrexone; Opioid-Related Disorders

2021
Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder.
    Drug and alcohol dependence, 2021, 04-01, Volume: 221

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Family; Female; Goals; Humans; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Perception; Professional-Family Relations; Treatment Outcome

2021
Payer strategies to ensure access to care for individuals with opioid use disorder during COVID-19.
    The American journal of managed care, 2021, Volume: 27, Issue:3

    Topics: Ambulatory Care; Buprenorphine; COVID-19; Health Services Accessibility; Humans; Insurance, Health, Reimbursement; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Telemedicine; United States

2021
Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Pain physician, 2021, Volume: 24, Issue:2

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Cross-Sectional Studies; Drug Monitoring; Female; Humans; Male; Methadone; Middle Aged; Naltrexone; Opioid-Related Disorders; United States; Young Adult

2021
Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure.
    Journal of substance abuse treatment, 2021, Volume: 124

    Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Humans; Injections, Intramuscular; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders

2021
Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort.
    Drug and alcohol dependence, 2021, 08-01, Volume: 225

    Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; United States

2021
Structural and organizational factors shaping access to medication treatment for opioid use disorder in community supervision.
    Drug and alcohol dependence, 2021, 09-01, Volume: 226

    Topics: Analgesics, Opioid; Buprenorphine; Health Services Accessibility; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2021
An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders.
    Drug and alcohol dependence, 2021, 09-01, Volume: 226

    Topics: Alcoholism; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2021
Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities.
    The American journal of psychiatry, 2021, 09-01, Volume: 178, Issue:9

    Topics: Alcoholism; Anorexia Nervosa; Attention Deficit Disorder with Hyperactivity; Comorbidity; Humans; Mental Disorders; Methadone; Naltrexone; Narcotics; Patient Outcome Assessment; Schizophrenia; Smoking; Varenicline

2021
A history of opioid abuse: Why buprenorphine is superior for the management of opioid use disorder and pain.
    Journal of opioid management, 2021, Volume: 17, Issue:7

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain

2021
Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.
    The American journal of emergency medicine, 2022, Volume: 51

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Hospital Mortality; Humans; Length of Stay; Logistic Models; Male; Methadone; Middle Aged; Naltrexone; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Prospective Studies

2022
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.
    Journal of substance abuse treatment, 2022, Volume: 136

    Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Female; Humans; Medicaid; Methadone; Naltrexone; Ohio; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Quality of Life; United States; Young Adult

2022
Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design.
    Medical care, 2022, 03-01, Volume: 60, Issue:3

    Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Buprenorphine; Cohort Studies; Cost Sharing; Female; Health Expenditures; Humans; Insurance, Health; Male; Medication Adherence; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; United States; Young Adult

2022
Perioperative Management of Patients on Maintenance Medication for Addiction Treatment: The Development of an Institutional Guideline.
    AANA journal, 2022, Volume: 90, Issue:1

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2022
Understanding and co-managing medication treatment options for opioid use disorder.
    Internal and emergency medicine, 2022, Volume: 17, Issue:7

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2022
Association of Medication-Assisted Therapy with New Onset of Cardiac Arrhythmia in Patients Diagnosed with Opioid Use Disorders.
    The American journal of medicine, 2022, Volume: 135, Issue:7

    Topics: Analgesics, Opioid; Arrhythmias, Cardiac; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies

2022
Acceptance of medications for opioid use disorder in recovery housing programs in Missouri.
    Journal of substance abuse treatment, 2022, Volume: 138

    Topics: Analgesics, Opioid; Buprenorphine; Housing; Humans; Methadone; Missouri; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2022
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community.
    Addiction science & clinical practice, 2022, 03-07, Volume: 17, Issue:1

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Overdose; Female; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain; Prospective Studies

2022
Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder.
    JAMA network open, 2022, 04-01, Volume: 5, Issue:4

    Topics: Analgesics, Opioid; Buprenorphine; COVID-19 Drug Treatment; Cross-Sectional Studies; Health Services Accessibility; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; United States

2022
Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey.
    Social science & medicine (1982), 2022, Volume: 305

    Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Surveys and Questionnaires

2022
Association of Bupropion, Naltrexone, and Opioid Agonist Treatment With Stimulant-Related Admissions Among People With Opioid Use Disorder: A Case-Crossover Analysis.
    The Journal of clinical psychiatry, 2022, 06-20, Volume: 83, Issue:4

    Topics: Analgesics, Opioid; Buprenorphine; Bupropion; Central Nervous System Stimulants; Cross-Over Studies; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2022
Emergency department utilization by individuals with opioid use disorder who were recently incarcerated.
    Journal of substance abuse treatment, 2022, Volume: 141

    Topics: Analgesics, Opioid; Buprenorphine; Emergency Service, Hospital; Humans; Infant, Newborn; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners; Retrospective Studies

2022
Effects of methadone, buprenorphine, and naltrexone on actigraphy-based sleep-like parameters in male rhesus monkeys.
    Addictive behaviors, 2022, Volume: 135

    Topics: Actigraphy; Analgesics, Opioid; Animals; Buprenorphine; Humans; Macaca mulatta; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Sleep

2022
Methadone use is associated with increased levels of sCD14, immune activation, and inflammation during suppressed HIV infection.
    Journal of leukocyte biology, 2022, Volume: 112, Issue:4

    Topics: Analgesics, Opioid; Cross-Sectional Studies; Cytokines; HIV Infections; Humans; Immunoglobulin G; Inflammation; Lipopolysaccharide Receptors; Methadone; Naltrexone; Pilot Projects; Receptors, Opioid, mu

2022
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants.
    Addiction science & clinical practice, 2022, 08-09, Volume: 17, Issue:1

    Topics: Buprenorphine; Humans; Methadone; Naltrexone; Nurse Practitioners; Opiate Substitution Treatment; Opioid-Related Disorders; Physician Assistants

2022
Attitudes toward Medication for Opioid Use Disorder among Substance Use Treatment Providers.
    Substance use & misuse, 2022, Volume: 57, Issue:12

    Topics: Analgesics, Opioid; Buprenorphine; Child; Female; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Treatment Outcome

2022
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    JAMA psychiatry, 2022, 10-01, Volume: 79, Issue:10

    Topics: Aged; Analgesics, Opioid; Buprenorphine; COVID-19; Drug Overdose; Female; Humans; Longitudinal Studies; Male; Medicare; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Telemedicine; United States

2022
Health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in Federally Qualified Health Centers and other primary care settings.
    PloS one, 2022, Volume: 17, Issue:10

    Topics: Analgesics, Opioid; Benzodiazepines; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cross-Sectional Studies; Delivery of Health Care; Humans; Medicaid; Methadone; Naltrexone; Opioid-Related Disorders; Primary Health Care; United States

2022
Optimally Choosing Medication Type for Patients With Opioid Use Disorder.
    American journal of epidemiology, 2023, 05-05, Volume: 192, Issue:5

    Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders

2023
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder.
    The American journal of psychiatry, 2023, 05-01, Volume: 180, Issue:5

    Topics: Buprenorphine; Drug Overdose; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders

2023
Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.
    Journal of substance use and addiction treatment, 2023, Volume: 149

    Topics: Buprenorphine; Criminal Law; Humans; Methadone; Naltrexone; Opioid-Related Disorders

2023
Augmenting project ECHO for opioid use disorder with data-informed quality improvement.
    Addiction science & clinical practice, 2023, 04-28, Volume: 18, Issue:1

    Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Quality Improvement; Surveys and Questionnaires

2023
Ventricular Arrhythmias Associated With Over-the-Counter and Recreational Opioids.
    Journal of the American College of Cardiology, 2023, 06-13, Volume: 81, Issue:23

    Topics: Analgesics, Opioid; Arrhythmias, Cardiac; Buprenorphine; Diphenoxylate; Humans; Loperamide; Methadone; Naltrexone; Nonprescription Drugs

2023
Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder.
    Journal of clinical psychology, 2023, Volume: 79, Issue:12

    Topics: Buprenorphine; Humans; Long QT Syndrome; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions; Retrospective Studies; United States

2023
Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances.
    Drug and alcohol dependence, 2023, Oct-01, Volume: 251

    Topics: Analgesics, Opioid; Buprenorphine; Cocaine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders

2023